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ABSTRACT 
 
 
Weight gain following kidney transplant is a significant problem with 50 to 90% 
of kidney transplant recipients gaining weight. Potential factors leading to weight gain 
following kidney transplantation have been thought to include a change in lifestyle such 
as dietary intake and physical activity, along with the use of immunosuppressant 
medications to preserve the newly implanted organ. Other influences affecting weight 
gain include genetic determinates such as age, gender and race. There is little data to 
confirm which of these factors may indeed lead to weight gain and obesity. The purpose 
of this study was to examine dietary intake and physical activity of kidney transplant 
recipients at baseline, 3 and 6 months following transplantation to identify contributing 
factors to weight gain.  
 
Methods: This descriptive, correlational study included secondary data to 
examine dietary intake, physical activity and other variables (e.g., age, race, gender and 
medications) associated with weight gain post kidney transplant for 44 participants, 18 
years or older. Three 24 dietary intake recalls (1 weekend day and 2 weekdays) and 7 
day-physical activity recalls (7D-PAR) were collected at baseline, 3 months and 6 
months post transplant. Nutrition Data System for Research (NDS-R), a Windows-based 
dietary analysis program, versions 2007, 2008 and 2009, (developed and coordinated by 
the Nutrition Coordinating Center, University of Minnesota, Minneapolis, Minnesota) 
was used to analyze dietary data. Weights were done at baseline, 3 and 6 months. 
Descriptive statistics and analysis of variance (ANOVA) for repeated measures were 
used to compare nutrient and physical activity changes. Pearsons’ product-moment 
correlation coefficient was used to describe the relationship of weight gain to other 
variables from baseline to 3 and 6 months. 
 
Results: In the total sample, weight gain increased from 172.46 ± 34.05 to 182.09 
± 38.38 from baseline to 6 months, indicating a 6% increase in weight. Body Mass Index 
(BMI) increased by 5% from 26.40 ± 3.80 to 28.24 ± 4.17 from baseline to 6 months. By 
race and gender, African American (AA) males and females gained 11.1 and 11.7 
pounds, respectively, while Caucasian males gained 9.3 pounds and Caucasian females 
gained 2.4 pounds. Dietary intake did not show statistical significance from baseline to 6 
months. By race and gender, kilocalories (p ≤ 0.05), total fat (p ≤ 0.035) and total 
carbohydrate (p ≤ 0.048) intake was higher in males than females. African American 
females had higher intake of these nutrients than Caucasian females. Hours of sleep for 
the total sample was reported as (p ≤ 0.02), which showed a decrease in the number of 
hours from baseline to 6 months. Moderate activity (p ≤ 0.046) showed a decrease in 
males and increase in females at 6 months. Hours per day of hard activity (p ≤ 0.04) 
increased in Caucasian females at 6 months. No relationship was demonstrated among 
dietary intake, physical activity and age, race, gender and immunosuppression at 6 
months.  
 
Conclusion: Kidney transplant recipients are at risk for weight gain from a 
number of factors. Little consideration has been given to what kidney transplant 
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recipients are eating and the effects of dietary intake on weight gain. Physical activity 
data from this study suggest that kidney transplant recipients are not changing their 
physical activity levels significantly by 6 months following transplantation. Further 
studies using a larger group should be considered. 
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CHAPTER 1. INTRODUCTION 
 
 
Overview 
 
 Kidney transplantation remains the treatment of choice for many persons in end-
stage renal disease. More solid organ transplants are being done throughout the world 
with life expectancy in some kidney recipients to exceed 40 years.1 With post transplant 
obesity and cardiovascular related issues being prevalent following transplantation, the 
focus of transplant research should transition to factors associated with these outcomes. 
These factors include lifestyle behaviors associated with nutrition and physical activity.  
 
 Weight gain following kidney transplant is a significant problem with 50 to 90% 
of kidney transplant recipients gaining weight.2 Findings from studies indicate a mean 
weight gain of 10 kg (22 pounds) in the first year after transplantation.3-4 In earlier 
studies, weight gain during the first year was reported equal to or greater than 10%.5,6   
 
More recently results from a large retrospective review of weight gain and body 
mass index (BMI) changes in the first year following kidney transplantation, Cashion and 
colleagues7 revealed weight gain ranging from 6.2 kg (13.6 pounds) to 32 kg (70.4 
pounds). As a result of weight gain, there has been an increase in morbidity and mortality 
in kidney transplant populations.8,9-12 
 
 Potential factors leading to weight gain following kidney transplantation have 
been thought to include a change in lifestyle such as dietary intake without concomitant 
increase in physical activity, along with the use of immunosuppressant medications to 
preserve the newly implanted organ. Other influences affecting weight gain include 
genetic determinates such as age, gender, and race2 and psychological factors related to 
stress.13 However, there is little data to confirm which of these factors may indeed lead to 
weight gain and obesity.   
 
Dietary intake remains an important factor following transplantation as nutrient-
related complications impact outcomes following kidney transplantation.14 There also 
exists a change in the nutrient needs following kidney transplantation with different 
dietary recommendations for the early, later and maintenance phases post transplant.15-17 
Several dietary-related  factors may contribute to weight gain following kidney 
transplantation including the transition from a restricted renal diet to one that is 
unrestricted, increased food intake resulting from feelings of well-being, and increased 
appetite and body fat composition from corticosteroids.2,16 
 
 Little is reported in the literature regarding the relationship of dietary intake to 
weight gain in post-kidney transplant recipients. Researchers in Mexico report 
significantly higher ingestion of proteins and fats than recommended dietary reference 
intakes (DRIs (p ≤ 0.05) in kidney transplant recipients in eight states in Mexico. As 
would be expected, body mass indexes (BMIs) were higher in those transplant recipients 
with the higher intakes of proteins and fats compared to those with less dietary intake of 
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these macronutrients.17 Other researchers recommend the importance of managing weight 
gain through dietary counseling and follow-up to prevent significant weight gain leading 
to obesity in kidney transplant recipient.6,7 Studies by Lopez and colleagues18 and Patel4 
have shown that dietary interventions with follow-up in the early post transplant period, 
can be effective in preventing excessive weight gain and that these dietary interventions 
may lead to weight loss.  
 
In addition to dietary intake, physical activity levels following transplantation 
may influence the amount of weight gained. Post-transplant activity may be limited 
resulting in decreased energy expenditure leading to post-transplant weight gain.19 In 
2001, Neilens and researchers20 reported on average, 25% less physical activity in their 
post-kidney transplant recipients compared to healthy subjects. Weight gain progressively 
increased in their participants over the five years studied.  
 
Activity or exercise is suggested by other researchers as an intervention in the 
prevention of weight gain following kidney transplantation but no specific guidelines are 
given.6,21 Long-term management of weight could possibly be achieved through regular 
physical activity following kidney transplant.22 
 
Immunosuppressant medications, needed for successful allograft maintenance, 
may be an additional factor in weight gain following kidney transplantation. The 
prolonged administration of medications such as high doses of corticosteroids can lead to 
adverse side effects including weight gain. Immunosuppressant medications can also 
affect body fat distribution and the retention of excess fluid may cause weight gain in the 
post transplant recipient.2,23 Significant hyperglycemia and post transplant diabetes are 
also common side effects of not only corticosteroids, but also seen with other 
immunosuppressive agents such as cyclosporine and tacrolimus.24  
 
In addition, cyclosporine, tacrolimus and sirolimus, along with corticosteroids 
may contribute to the metabolic changes following kidney transplantation as the body is 
attempting to adjust from its previous state of uremia. These medications, coupled with 
changes in metabolic and body composition alterations put these recipients at risk for 
cardiovascular events.1  
 
Recently, steroid free or early steroid withdrawal protocols have been employed 
following kidney transplantation25 to reduce or eliminate side effects such as weight gain. 
However, results of several studies have demonstrated similar weight gain following 
kidney transplant in participants on steroid-free protocols as well as those on steroid 
protocols.6,26,27 
 
Genetic factors including age, gender and race may be factors leading to weight 
gain following kidney transplantation. Several studies report a genetic predisposition 
related to race and gender.4,7,28 Correlates of weight gain following kidney transplantation 
were found higher in African Americans than in Caucasians and higher in females and 
younger patients.6 
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 In addition, psychological factors can also affect weight gain in these patients. 
Psychological factors related to stress are common among patients following kidney 
transplant.13 Among the stressors are fear of organ rejection and the fact that patients 
must continue contending with a chronic illness.29 
 
 Detection of patients at risk for weight gain and obesity in the period following 
kidney transplantation combined with early intervention and monitoring may prevent or 
delay development of co-morbid disease leading to morbidity and mortality. With longer 
survival rates in post transplant kidney recipients, risk factor management, particularly 
management of cardio-vascular risk factors related to weight gain need additional study 
for the reduction of these and other weight-related outcomes.2 
 
 
Problem Statement 
 
Weight gain following kidney transplantation is a significant problem. Co-
morbidities associated with weight gain in kidney transplant recipients include post 
transplant diabetes and cardiovascular disorders. Increased dietary intake, low levels of 
physical activity and the effects of immunosuppressant medications could contribute to 
weight gain following kidney transplantation. To tailor better dietary and physical 
activity interventions to transplant recipients, dietary and physical activity following 
kidney transplantation need to be characterized. In addition, associations among these 
contributing factors need to be established. By identifying contributing factors to weight 
gain in this population, tailored interventions can be planned and implemented to abate a 
significant increase in weight following kidney transplantation. 
 
 
Purpose 
 
The purpose of this study was to examine dietary intake and physical activity of 
kidney transplant recipients at baseline, 3 and 6 months following transplantation to 
identify contributing factors to weight gain. Using data from a larger longitudinal 
prospective study entitled “Genetics, Environment, and Weight Gain Post-transplant,” the 
secondary data analysis answered different questions than proposed in the parent grant. 
Long term goal of the study was to use the identified factors associated with weight gain 
following kidney transplant to design individualized dietary and activity protocols that 
can be tailored to these recipients to avoid clinically significant weight gain in the first 
year following transplant. This would lead to a decrease in co-morbid conditions 
potentially decreasing mortality among at-risk individuals.  
 
 
Specific Aims  
 
1. Characterize micro and macronutrients in kidney recipients’ dietary intake at 
baseline, 3 months and 6 months following transplantation. 
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2. Characterize physical activity at baseline, 3 months and 6 months following 
kidney transplantation. 
 
3. Determine the relationship among dietary intake, physical activity, and other 
factors (i.e., age, gender, race, medications) to weight gain in post kidney 
transplant recipients.   
 
 
Questions 
 
1. Do kidney transplant recipients increase their food and calorie intake following 
transplantation, and if so, to what extent and at what time point? 
 
2. Do kidney transplant recipients increase their physical activity following 
transplant and, if so, to what extent and at what time point? 
 
3. What is the relationship of dietary intake, physical activity, and other factors (i.e., 
age, gender, race, and medications) to weight gain in post-kidney transplant 
recipients? 
 
 
Significance of the Study 
 
Weight gain following kidney transplantation can progress to obesity leading to 
poor health outcomes including coronary artery disease, hypertension, hyperlipidemia, 
and post-transplant diabetes.3,30 The leading cause of death in long-term kidney transplant 
recipients was cardiovascular disease.31    
 
There is lack of evidence as to why some kidney transplant recipients 
progressively gain weight. Moreover, there is little information on dietary intake of 
kidney transplant recipients reported in the literature. To date, few interventional trials 
have been conducted examining dietary intake and weight gain in the early transplant 
period.   
 
Low activity levels following kidney transplantation may play a role in the 
development of weight gain. Individuals with end stage renal disease generally 
experience a sedentary lifestyle which can continue following transplantation. These 
recipients can experience muscle de-conditioning, exercise intolerance and fatigue.  
 
There is currently a gap in the literature reporting macro and micronutrient intake 
and physical activity of post kidney transplant recipients. The issue of weight gain 
following kidney transplantation is a significant area of research to determine which 
individuals are more at risk and how unintentional weight gain can be avoided. This 
secondary data analysis addressed the issue of weight gain following kidney 
transplantation. If successful, explicated the relationship of dietary intake and physical 
activity to weight gain and serves as a foundation for interventional studies in this area.  
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Definitions of Terms 
 
Terms will be defined as they are used in the study. Terms to be defined include 
nutrient, macronutrient, micronutrient, and dietary reference intakes (DRIs).Other terms 
defined are physical activity, immunosuppression, weight gain and body mass index 
(BMI). 
 
For this study, the term nutrient is defined as constituent substances in foods 
necessary for chemical processes related to human tissue conservation, growth and repair. 
These food constituents are proteins, fats, carbohydrates, vitamins, minerals and water.32   
 
Macronutrients, organic substances made up of carbon compounds, include 
carbohydrates, triacylglycerols (i.e., fats or lipids) and proteins or amino acids. These 
macronutrients serve as major energy sources for the human organism; hence, large 
quantities are required for cellular functioning. Excess substrates of these macronutrients, 
not used for energy are stored by the body for use later.32 
 
Micronutrients are substances essential in small quantities for metabolic functions 
and growth and are not used for energy. Organic micronutrients are known as vitamins, 
while inorganic micronutrients are known as minerals.32 
 
Dietary reference intakes (DRIs), are defined as reference values that are 
measurable or quantifiable for dietary intake of micro and macronutrients. DRIs also 
refer to the highest bounds for a nutrient intake that is deemed safe for human 
consumption.33  
 
Weight gain is defined as added body mass when adipose tissue is stored. This 
can result from an imbalance in caloric intake as opposed to calories expended.34 If 
energy is not spent from the caloric intake from foods, then the individual stores the 
excess energy in the form of fat or adipose tissue. According to Hill and Melanson,34 
genetic and environmental factors also play a role in this energy balance, or imbalance, 
leading to weight gain from extra stored fat. 
 
Body mass index (BMI) is defined as a number representative of a person’s height 
in relation to weight. It can be calculated by an individual’s weight measured in 
kilograms, divided by the square of a person’s height in meters (kg/m²). According to the 
World Health Organization’s (WHO’s) classification of BMI in 2010, underweight is a 
BMI of less than 18.5. Normal weight is considered for a BMI up to 24.9. BMI equal to 
or greater than 25 constitutes overweight status. Pre-obese classification has been added 
and is a BMI of 25.00-29.99, while obesity is classified as a BMI equal to or greater than 
30. The WHO further delineates the classifications of obesity as: obese class I, 30.00 - 
34.99; obese class II, 35.00-39.99; and obese class III, equal to or greater than 40.00.35 
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Physical activity is defined as movement in the body through skeletal muscle 
action producing energy usage above resting metabolic state. This movement in the body 
does not have to be categorized as exercise, as some activity can be divided into light 
activities such as slow walking and standing. Walking briskly, lifting weights and yoga 
are examples of physical activities that produce energy above a basal level and are 
considered beneficial in lowering risk of some types of health issues such as diabetes 
mellitus and cardiovascular related disease.36  
 
When categorizing activities, the term metabolic equivalent (MET) is defined as 
the ratio between metabolic rate when working and metabolic rate at rest.37 Activities can 
be divided into light, moderate, hard and very hard activities according to the intensity. 
Physical activity lasting 10 minutes or longer and of at least moderate intensity, are used 
to assess energy expenditure in some clinical trials.37,38 
 
Immunosuppression is defined as a medical therapy used to obstruct the body’s 
natural defense mechanisms inherent in the immune system to the newly transplanted 
kidney. This is achieved through the use of immunosuppressant medications to preserve 
the functioning of the organ and to avoid allograph rejection.39 The balance of 
immunosuppression is important to prevent graph rejection as well as prevent 
superimposed infections, certain types of malignant tumors and to lessen or avoid side 
effects.40,41 During and immediately after kidney transplantation, when acute allograph 
rejection is highest, the induction phase of immunosuppression is started followed by a 
maintenance phase.24,41 Common immunosuppression currently used following kidney 
transplantation include calcineurin inhibitors (CNIs) such as cyclosporine and tacrolimus 
or FK560 (Prograf), mycophenolate mofetil or MMF (Cellcept), mammalian target of 
rapamycin (mTOR) or (sirolimus) and corticosteroids (prednisone and 
methylprednisolone).41,42  
 
 
Assumptions 
 
This study had several assumptions about the association between dietary intake, 
physical activity, immunosuppression and weight gain following kidney transplantation: 
 
1. Dietary intake increases from baseline to 3 and 6 months post transplant, 
contributing to weight gain.  
 
2. Low levels of activity are maintained for most transplant recipients that mirrors 
activity prior to transplantation and is a contributing factor to weight gain. 
 
3. Immunosuppression is a contributing factor to weight gain following 
transplantation.  
 
4. Women will, in general, gain more weight than men following kidney 
transplantation. 
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5. African-American participants will, in general, gain more weight than Caucasian 
participants following kidney transplantation.  
 
 
Limitations 
 
 This study used 24-hour dietary intake recalls as a method of assessing micro and 
macronutrient intake. This type of dietary intake assessment is a self-report and relies on 
participant memory to recall the previous day’s dietary intake. Researchers have 
identified that compared to healthy controls, kidney transplant recipients show increased 
difficulty in cognitive measures such as learning and memory.43 These findings suggest 
that memory could be affected in some kidney transplant recipients, thus impacting their 
ability to accurately recall dietary intake. In contrast, researchers report an improvement 
in memory in kidney transplant recipients when compared to their cognitive functioning 
prior to transplantation.44 These data suggest that improvement in cognitive functioning 
following kidney transplantation might be a positive factor in these transplant recipients’ 
ability to recall dietary intake data.  
 
 Although there are limitations with this type of data collection, some strengths of 
the 24-hour dietary intake are built into the Nutritional Data System for Research (NDS-
R), the nutrient data system used for analysis. With this nutritional data system, dietary 
intake data are obtained using a multisystem approach. This allows the recipient multiple 
chances to recall dietary intake. Opportunities to provide detailed descriptions of foods 
and to describe portion sizes are also a part of the system.45 In the United States, the 24-
hour dietary recall method is the type of dietary assessment most often used for collection 
of dietary intake.46   
 
 Another limiting factor in this study was the use of a 7-day activity recall, which 
requires participants to recall the previous 7 days’ activities, including a summary of the 
previous 3 months’ activities. This type of activity recall also relies on the memory of 
participants. It also does not take into account specific factors such as gender, age and 
body type when estimating how much energy is used in activities.47 However, 
participants are encouraged to recall as accurately as possible and are reminded of the 
importance of data that will assist in identifying factors leading to weight gain.  
  
There are also limitations such as participant dropout and graft loss which are 
inherent when conducting clinical research with kidney transplant recipients. These were 
controlled for in data analysis. 
 
The inability to generalize the findings of this study to other kidney transplant 
populations was an additional potential limitation. Although several adjacent southern 
states are represented by the participants in this study, all recipients were recruited from 
the same urban transplant clinic. However, the sample was racially diverse, as almost 
equal numbers of African-American and Caucasian recipients participated in this study.    
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Conceptual Model 
 
The framework that guided this study included the key variables of dietary intake 
and physical activity and their association to weight gain following kidney 
transplantation. The relationships among variables such as age, gender, race and 
immunosuppressant medications to weight gain following kidney transplantation were 
examined. The conceptual model for this study is depicted in Figure 1.1. 
 
Justification for selecting these variables included literature searches related to 
previous research in post kidney transplant recipients. A gap in the literature was noted, 
with little nutritional data reported, although a few interventional trials have been 
conducted examining dietary intake, weight gain, and the impact of metabolic syndrome 
in the early transplant period.1 Further justification for characterizing dietary intake was 
that past research targeted allograph rejection and advances in immunosuppression 
medication regimes in order to preserve the newly transplanted kidney. With post 
transplant obesity and cardiovascular related issues being prevalent following transplant, 
the focus of transplant research now is shifting to clinical nutrition.1 
 
 In all likelihood, transplant recipients return to a diet high in calories, fat and 
carbohydrates once they no longer have to follow a highly restricted renal diet. In 
addition, resolution of uremia after transplantation makes food taste better and may result 
in additional intake. Increased appetite and treatment with immunosuppressant 
medications may also be factors in weight gain following kidney transplantation.15 
Because there is a gap in the literature characterizing dietary intake following kidney 
transplantation to weight gain, it was a primary variable in the conceptual framework. 
 
Physical activity following kidney transplantation may be limited, resulting in 
decreased energy expenditure leading to post-transplant weight gain.19 Neilens and 
colleagues20 reported 25% less physical activity in their post-kidney transplant recipients 
compared to healthy subjects and progressive weight gain over a 5 year period. Because 
few studies characterize physical activity in post-kidney transplant recipients and it has 
been shown to be strongly associated with weight gain across populations, it was another 
primary variable in the conceptual framework. 
 
Non-modifiable factors such as age, gender, and race may predispose a transplant 
recipient to weight gain. Age has been shown to be a correlate of weight gain in some 
studies, with younger adults gaining more weight than older adults following kidney 
ransplantation.6,28 Women have been shown to gain more weight than men post 
transplant. When comparing African American recipients to Caucasians, there is a greater 
weight gain at 1 year in African Americans.3  
 
Immunosuppression medications have been implicated in previous studies as 
having a significant association with weight gain.48 However, early withdrawal of 
steroids is employed to limit weight gain following kidney transplantation.9,23,49 Elster 
and researchers26 found that kidney transplant recipients gained weight regardless of the 
immunosuppressant protocol. 
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Figure 1.1  Post Transplant Weight Gain Model 
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In the current study, most recipients were on four types of immunosuppression 
medications, tacrolimus, mycophenolate mofetil, and sirolimus, along with prednisone. 
Because there will be little variation, it was not expected to be a major factor in weight 
gain following kidney transplantation. 
 
Findings from this study contribute to existing knowledge about post-transplant 
weight gain in kidney transplant recipients by identifying associations between various 
nutrient intakes, levels of physical activity and medications post transplant as depicted in 
the framework. Knowledge of significant weight gain at specific time points would assist 
in guiding interventions and patient teaching regarding how to prevent weight gain. Pre 
and post-transplant interventions regarding the types of nutrient intake, physical activity 
and medications that contribute to weight gain could be devised in a collaborative effort 
among nurses, physicians and dietitians. Detailed plans could be tailored to persons 
awaiting transplant according to age, gender and race to prepare them for positive 
outcomes post transplant. These data could be the basis for further interventional studies 
with post-transplant recipients.  
 
Summary of the Chapter 
 
 Following the problem statement, this chapter included a discussion of (a) 
purpose, along with specific aims and questions, (b) significance, (c) definitions of terms, 
(d) assumptions, (e) limitations, and (f) conceptual model of the study. The effects of 
dietary intake, physical activity, and medications used for immunosuppression are 
important factors that could lead to post transplant weight gain. As in the general 
population, weight gain can lead to co-morbidities such as obesity, diabetes mellitus, and 
cardiovascular issues; for post kidney transplant recipients; these co-morbidities can 
occur with weight gain as well. The intent of this study was to determine the association 
between dietary intake, activity, age, race, gender, and immunosuppression and weight 
gain post kidney transplant.     
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CHAPTER 2. REVIEW OF LITERATURE 
 
 This chapter presents pertinent literature related to the concepts in this study. The 
first section provides research-based information related to weight gain in the general 
population and in kidney transplant recipients. The second section addresses dietary 
intake in kidney transplant recipients. The third section contains research-based 
information on physical activity in post kidney transplant recipients. The next section 
integrates transplant immunosuppressant medications and nutrient interaction. The final 
section summarizes this chapter. 
 
 
Weight Gain 
 
 
Weight Gain in the General Population 
 
 Nationally, the prevalence of overweight and obese adults has been trending 
upward in the United States over the past 40 years.50 In the most recent data related to 
obesity in the National Health Examination Survey (NHANES), a sample of 8,082 adults 
aged 20 and over, from both genders, showed 34.2% of adults in the United States were 
overweight in 2007-2008, and 33.8% were obese. More men (72.3%) were overweight or 
obese than women (64.1%).51  
 
Globally, WHO estimates that 1.6 billion adults are overweight, while obese 
adults number 400 million.51 Global increases predicted in the year 2015 could reach 
about 2.3 billion overweight adults, while obese adults will be greater than 700 million.51 
By the year 2020, if the trend in overweight and obese adults continues, it is predicted 
that nearly half of the adults in the US will be obese, according to the World Health 
Organization’s (WHO) criteria for obesity.52 Excess adipose tissue places individuals at 
risk for the development of type 2 diabetes mellitus, hypertension, ischemic heart disease, 
hyperlipidemia and other chronic diseases.51   
 
Body mass index (BMI) is commonly used to categorize weight in individuals 
using both the person’s height and weight for a more accurate representation of a 
person’s body fat than just using weight itself. Researchers have shown that BMI is a 
correlate of other methods measuring amount of body fat, such as dual energy x-ray 
absorptiometry (DEXA) and measurement of weight underwater.53 BMI, used to assess 
groups for classification of overweight and obese categories, is inexpensive to use and 
allows individuals to compare their weight category to others.  However, BMI is higher 
in some groups and would not necessarily mean that an individual has excess fat tissue. 
For example, athletes who have more muscle mass might be in a higher BMI category, 
even though they do not have excess fat tissue.54 
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Health Outcomes of Weight Gain in Healthy Adults 
 
The impact of weight gain in healthy adults has serious health consequences, with 
increasing morbidity and mortality.55 Weight gain leading to excess body weight is well 
documented to be a prime risk factor for disorders of the cardiovascular system such as 
coronary artery disease (CAD), hypertension and hyperlipidemia.55,51 Additional 
disorders linked to excess body weight are type 2 diabetes, some cancers and disorders of 
the musculoskeletal system.51 Not only does weight gain increase the prevalence of the 
previously mentioned disorders, it can also cause exacerbations, or worsening, of existing 
chronic disease in these individuals leading to more negative outcomes.55 
 
 
Weight Gain in the Post Kidney Transplant Recipient 
 
Weight gain and obesity have been noted in post kidney transplant recipients.3-5,7 
In a retrospective review of 974 kidney transplant recipients between July 1993 and April 
1998, weight changes were analyzed. At 1 year following transplantation, the mean 
weight gain was 10.3 kg (22.6 lbs.), with a range of 75 to -23 kg or median of 10 kg (22 
lbs.). Greater weight changes were seen in blacks (117.3%) compared to whites 
(113.2%), p ≤ 0.0004. Women gained more than men (118.4% and 112.1%, respectively), 
p ≤ 0.0001. Age showed an inverse correlation with weight gain (p ≤ 0.0002).3 
 
Another retrospective review of 506 kidney transplant recipients between 1983 
and 1999, reported at one year following kidney transplantation, African-Americans had 
gained significantly more weight (13.6 kg) than whites (9.1 kg) and others (9.5 kg). This 
increase in weight was also shown at 2 and 3 years following kidney transplantation with 
mean weight gains for African Americans of 16.2 kg and 16.4 kg  compared to 
Caucasians, 11.5 kg and 11.1 kg at years 2 and 3, and 11.5 and 11.6 kg in others at years 
2 and 3, respectively.48 
 
In a prospective study of 50 kidney transplant recipients, researchers found that 
mean weight gain for all participants was 4 kg (8.8 lbs), p ≤ 0.0001, for the first 6 months 
following kidney transplantation. It was also noted that 30% (4 females, 11 males) of the 
participants did not gain or lose weight during the first 6 months. More incidents of post 
transplant complications, (i.e., allograft rejection and infection) occurred in the group that 
did not gain weight or lose weight. Contributing factors in the group that did not gain or 
lose weight could have been related to stress, catabolism, continued uremic state, delayed 
sense of well-being and altered dietary intake related to hospitalizations and treatment for 
rejection and infection.  Females gained more than males (8 kg verses 7 kg, respectively). 
Researchers concluded that early dietary intervention for female recipients might be 
warranted, but further studies are needed to design weight control protocols.5   
 
In a more recent prospective study, Cashion and colleagues7 found that there was 
an increase in mean weight (6.2 ± 10.7 kg) during the first year following kidney 
transplantation. Of the 171 individuals in the study, 70% were overweight or obese at the 
time of transplant. This was compared to a group of individuals reported in the list 
obtained from the United Network for Organ Sharing (UNOS) that indicated that 60% of 
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those in the national database were overweight or obese at the time of transplant. This 
indicates that not only is weight gain important to note following surgery but also many 
of these transplant recipients are overweight or obese at the time of transplant. More 
weight gain has been documented in patients who are moderately obese at the time of 
transplant than in non-obese patients.3,56  
 
El-Agroudy and research team23 documented that weight gain occurred in the first 
6 months following transplant and that weight gain tended to increase after that but at a 
slower rate. They speculated that this weight gain could be attributed to nutritional intake, 
lessened rates of activity and a higher amount of steroids in their pharmacological 
protocol.  
 
A literature review done by Pischon and Sharma57 of nine studies in 2001, 
indicated that significant weight gain in patients categorized as non-obese and obese was 
seen in individuals after kidney transplantation. Weight gain in non-obese transplant 
recipients was reported as 9 kg, as compared to obese individuals who gained 14 kg in 
the year following transplantation.58 Still another study reviewed by Pischon and 
Sharma’s57 reported weight gain of 8.5% in both non-obese and obese recipients 1 year 
following transplantation.59 Similarly a 10.9% weight increase at 1 year post 
transplantation increased to 15.3% over a 5-year period.6  
 
These studies support that weight gain occurs in post kidney transplant recipients 
regardless of the pre-transplant weight status. Weight gain is more pronounced during the 
first year following transplantation. 
 
 
Dietary Intervention Studies in Post Kidney Transplant Recipients 
 
Some studies have tested dietary interventions in post kidney transplant recipients 
to investigate weight gain and outcomes following transplantation. To determine the 
effect of a dietary intervention on weight gain following kidney transplantations, Patel 
and colleagues included 32 study participants in 2 groups. The intervention group (Group 
A) was given individualized dietary advice for the first 4 months following 
transplantation. This group, consisting of 11 participants (9 males, 2 females), was 
followed prospectively for 1 year. In contrast, the second group (Group B) was not given 
any dietary guidance or follow-up. Mean weight for Group A was 67kg ± 13 kg at 
baseline, 69kg ± 12 kg at 4 months and 73kg ± 12 kg at 12 months compared to Group B, 
mean weight 67kg ± 11 kg at baseline, 74kg ± 9 kg at 4 month and 79kg ± 12 kg at 12 
months. Both groups gained weight; however, mean weight gain of 5.5 kg per recipients 
was seen in the intervention group compared to a mean weight gain of 11.8 kg per 
recipient in Group B. Researchers concluded that dietary intervention during the early 
post transplant period, along with follow-up, could be a factor in limiting the amount of 
weight gained during the first 12 months following kidney transplantation.4   
 
In another nutritional intervention study involving 23 (16 females) kidney 
transplant recipients, researchers in Spain reported mean weight loss was 3.2 kg ± 2.9 kg 
after 6 months. Initial body weight (kg) was 77kg ± 13kg, with final body weight of 74 
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kg ± 12kg (p < 0.001) for the total group. The dietary intervention used in this study was 
the American Heart Association Step One pattern. Along with improvement in body 
weight, there was an improvement in total cholesterol (237 mg/dL to 224 mg/dL; p < 
0.05) in males, along with a reduction of low-density lipoprotein cholesterol of 136 
mg/dL from 156 mg/dL, p < 0.05. Low-density lipoprotein values were not affected in 
females following the nutritional intervention. Researchers concluded that obesity, as 
well as hyperlipidemia could be reduced after dietary intervention.60   
    
Improvement in body mass index (BMI) and metabolic syndrome were found 
during the first year post kidney transplant by Bellinghieri and colleagues61 in 2009, 
using a diet low in fat and calories. While tapering steroids, these investigators found that 
with the dietary intervention, BMI could be reduced. 
 
In 2007, Guida and colleagues,56 documented improvement in nutrition, body fat 
and weight during the first year following kidney transplant by prescribing a low fat and 
low calorie diet during their trial. In addition, improvements were seen in cholesterol 
levels, fasting serum glucose and albumin. Data from a study by Guida and his research 
team56 suggest that referrals made to dieticians early in the post transplant period, helped 
to prevent weight gain. They found that by doing repeated dietary assessments on their 
patients, they observed better compliance in their patients resulting in energy balance and 
an improvement in their nutritional status. Consistent weight loss was demonstrated by 
their patients, especially in males who followed a diet lower in protein, cholesterol and 
sodium. 
 
 
Health Outcomes Related to Weight Gain in Kidney Transplant Recipients 
 
 It is recognized that weight gain following kidney transplant poses undesirable 
health outcomes, such as a higher incidence of cardiovascular disease (CAD), including 
hypertension and hyperlipidemia, post transplant diabetes mellitus (PTDM) and 
obesity.1,2,62  The leading cause of death in kidney transplant recipients is CAD.1 
However, there are conflicting results in studies reviewing the effects of obesity on 
outcomes following kidney transplantation.63 
 
 A retrospective review of 427 kidney transplant recipients between 1987 and 
1992 reported that 50 of their participants developed atherosclerotic CAD in the post-
transplant follow-up period, which was 28.6 ± 20.2 months. Coronary artery disease 
occurred more frequently (9.8%), in their participants. Other cardiovascular-related 
incidents were peripheral vascular disease (2.7%) and cerebrovascular disease (1.6%). 
Forty-six percent of these 50 participants exhibited CAD prior to transplantation. Out of 
the 427 recipients studied, 34 deaths occurred after transplantation of which 32.4% were 
attributed to cardiovascular complications and 35.3% were related to infection—still 
making deaths from infection as the main cause of mortality in this study.64 
 
 In a prospective study of 506 kidney transplant recipients between 1983 and 1998, 
the most common cause of death (40%) was related to CAD. African Americans had the 
highest frequency of death from cardiovascular disease (n = 20), followed by Caucasians 
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(n = 7) and other (n = 5). Post-transplant diabetes (PTDM) had developed in 66 recipients 
(32%) during the first year following kidney transplantation. Nonwhite participants 
(African Americans and others) were two times more likely to develop PTDM than 
whites.48  
 
 
Dietary Intake in Kidney Transplant Recipients 
 
 
Overview of Biochemical Processes in the Kidney Related to Nutrition 
 
Biochemical processes in the kidney are complex and relate to nutrition by 
regulating vitamin D, calcium and phosphorus, electrolyte balance (sodium, chloride, 
potassium) and maintaining acid-base balance. Gluconeogenesis, amino acid metabolism, 
fatty acid metabolism and maintaining water balance in the body are other biochemical 
processes in the kidney.65 
 
Prior to receiving a kidney transplant, individuals undergo hemodialysis, usually 
for a number of years, as a treatment for end state renal disease (ESRD). Due to the 
nonfunctioning kidneys, these biochemical processes in the kidneys are altered. Thus, 
health care providers must consider the nutritional needs of persons in end-stage renal 
disease and in the period following kidney transplantation. 
 
Calcium homeostasis is an important biochemical process performed by the 
kidneys related to the production of the active form of vitamin D, 1-25-dihydroxy vitamin 
D or calcitrol. This active form of vitamin D facilitates the absorption of calcium and 
phosphorus in the intestines. The kidney’s response to calcitonin and parathyroid 
hormone is important in maintaining calcium balance.65,66 
 
Calcium ions are necessary for all cells of the body and are important in the bone 
mineral composition. Calcium ions are filtered in the glomerulus and are reabsorbed by 
the renal tubules. This movement of calcium is accomplished through calcium channels 
or by passive movement. Sodium/calcium exchangers, or Calcium adenosine 
triphosphatase (calcium ATPase), is responsible for this ionic movement in the distal 
tubules.65  
 
Calcium binds with a protein, calbindin, within the cytoplasm. In order to 
activate, calbindin requires 1, 24-dihydroxy vitamin D. The formation of 1, 24-dihydroxy 
vitamin D is stimulated by parathyroid hormone, PTH, which also promotes excretion of 
phosphate in the urine.65  
 
Another important biochemical process in the kidney related to nutrition is the 
active transport of potassium and sodium into and outside the cell. The enzyme sodium/ 
potassium adenosine triphosphatase (sodium/ potassium-ATPase), present in the 
ascending loop of Henle and the proximal tubules has a role in this process. Through 
active transport system which depends on ATP for energy, sodium chloride is reabsorbed 
from the tubules into the peritubular space. D-glucose and amino acids are transported 
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into the blood along with sodium. With leakage of potassium into the lumen, more 
sodium is caused to move into the cell. Potassium is lost via both an active and a passive 
system, thus potassium is always excreted regardless of the amount consumed. Sodium, 
on the other hand can be decreased if little is consumed. Chloride ions are actively 
transported along with the sodium ions.67   
 
Involved in maintaining acid-base balance, hydrogen ions are secreted into the 
urine via the proximal portion of the renal tubules by sodium/hydrogen exchangers and 
hydrogen-ATPaseses. Hydrogen ions are used as substrates for the sodium/hydrogen 
exchangers in the ascending loop of Henle, and excess hydrogen is excreted. Ammonia is 
secreted by the α- intercalated cells forming ammonium. Bicarbonate is secreted by the β-
intercalated cells and reabsorbed in the tubules to maintain acid-base balance. 
Gluconeogenesis occurs in the renal cortex but does not supply a significant amount of 
glucose to the body. Fasting states increase gluconeogenesis, as does hormones of 
epinephrine and glucagon by cAMP. During fasting states, fatty acids and ketone bodies 
are the energy sources for gluconeogenesis, and phosphoenolpyruvate carboxykinase is 
the enzyme. Acidotic states cause increase in messenger RNA, which increases the 
production of this enzyme.68 Amino acid are catabolized through deamination, which 
results in cleaving off an amino acid group from the molecule, resulting in ammonia and 
keto acid. The kidney uses glutamine that is hydrolyzed to ammonium ion and glutamate, 
which then gets oxidized to α-ketoglutarate. This process of ammonia production begins 
with an enzyme, phosphate-dependent glutaminase, located within the matrix of the 
mitochondria. During acidosis, ammonia is formed by increased activity of glutaminase 
glutamate and by an increased transport of glutamine into the mitochondria.67  A small 
amount of ammonia is excreted by the kidneys, with the remainder incorporated into 
urea. Uric acid is formed by the degradation of purines, whereas the resultant nitrogen 
from degradation of pyrimidine is excreted as urea in the urine.69  
 
Creatine phosphate, found in muscle, is changed to creatine and excreted by the 
kidneys. Since creatine is not reabsorbed by the renal tubules, it is used as a measure of 
kidney function.69  
 
Finally, maintaining water balance in the body is achieved through the kidney’s 
ability to stabilize fluid volume and regulate osmolarity of body fluids. The kidneys have 
the ability to remove excess substances and water and to conserve deficit substance and 
water.  
 
One of the mechanisms to explain fluid balance is in reference to plasma 
osmolarity. The ratio of NaCl to total body water is affected by excess or decreased 
amounts of water. Physiological feedback mechanisms assist in stabilizing plasma 
osmolarity. Feedback mechanisms for blood volume and blood pressure changes also 
affect thirst and excretion of water through the kidneys.70   
 
Circulating arginine vasopressin (AVP), a small peptide made up of amino acids, 
is responsible for regulating the concentration of the urine, whereas, aquaporins, or 
transport proteins, primarily AQP-2, are responsible for transporting water in the tubular 
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epithelium. The binding of AVP to receptors activate adenylate cyclase which increases 
cyclic AMP to activate AQP-2 to move the water. The opposite functions occur when 
AVP is removed and AQP-2 water channels are reincorporated back into the cell, so the 
membrane is no longer permeable to water.70  
 
 
Dietary Recommendations for Pre-transplantation Period 
 
It is important in the pre-transplantation period to manage recommended dietary 
intake in individuals with chronic kidney disease (CKD) to maintain muscle mass, create 
a positive nitrogen balance and to prevent increased fat mass. The effects of CKD and 
hemodialysis impact the nutritional state of individuals awaiting kidney transplant. An 
increasing issue in these individuals is the number of overweight or obese persons 
awaiting transplantation, as 60% of obese transplant recipients were reported between 
1987 and 2001.71 These individuals in the pre-transplant period should be monitored by 
health care providers to maintain optimal nutritional status and to prevent some nutrient 
related complications post transplant such as overweight or obesity. 
 
According to the National Kidney Foundation’s Kidney Disease Outcome Quality 
Initiatives (KDOQI),72 recommendations for daily energy intake in individuals with end 
stage renal disease (ESRD) is similar to recommendations in healthy adults. Based on 
metabolic studies of persons being treated for ESRD by maintenance hemodialysis, 
KDOQI72 recommends 35 kcal/kg/d for those below 60 years of age and 30 to 35 
kcal/kg/d for those older than 60, according to their level of physical activity, to maintain 
neutral nitrogen balance.  
 
Protein intake for persons in ESRD has been a controversial issue in the literature. 
As noted in the KDOQI guidelines, these persons can be malnourished due to a number 
of causes, including poor nutrient intake related to decreased appetite, depression and 
acidemia. Issues with amino acid removal with the dialysate as well as the hypercatabolic 
nature of the illness or dialysis may also contribute to poor nutritional status. Daily 
protein intake is currently recommended at 1.2 g/kg weight/d. This amount for protein 
intake would likely produce neutral or positive nitrogen balance for most persons who are 
clinically stable.73 Traditionally, protein intake has been restricted to 0.6-0.8 g/kg/day, 
but now, may be reserved for those persons not on dialysis, to slow the progression of the 
disease.74  
 
The percent fat intake would be tailored to the individual related to cardiovascular 
risk factors but is generally recommended to be 20-30% of the energy intake.74 If high 
risk for CVD is present, then the recommendations are less than 10% saturated fat and 
250-300mg cholesterol per day.66 Percent carbohydrate should make up the remainder of 
the nonprotein calories75  
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Dietary Recommendations following Kidney Transplantation 
 
The management of dietary intake recommendations for kidney transplant 
recipients with functioning allografts impact outcomes related to morbidity and 
mortality.25 Dietary recommendations for the renal transplant recipient in the early post-
tranplant period is recognized by Blue76 as 4–6 weeks following surgery and defined by 
Wilkinson77 as the first 3 months post-transplant. With functioning allograft, kilocalorie 
requirements are specified as 30–35 kcal/kg body weight/day and protein 1.3–
2.0g/kg/body weight/day.16,25 Meeting adequate needs for energy and protein to prevent 
post operative complications of infection, decreased wound healing and loss of muscle 
mass is a goal of nutritional intervention. These recommendations would also promote 
calcium and phosphorus balance to minimize bone loss in these recipients.15 Percent 
calories from fat are recommended at 30–35%,16 and percent calories from carbohydrates 
at 50%.16,76  
  
In this early transplant period, normal kidney functioning is supported and 
continues to be established and maintained. During this time, kidney transplant recipients 
have certain dietary recommendations to support their hemodynamic and electrolyte 
balance. Mineral recommendations for these individuals include sodium intake of 3000–
4000 mg per day if unrestricted. However, if hypertension, edema, fluid retention and 
absence of urine output are issues, sodium intake is restricted.16 In the presence of 
hypertension related to calcineurin inhibitors sodium would be restricted to 2000 mg 
daily.25 In contrast, 80 to 100 mmol/day (1440mg–1800 mg) of sodium intake is 
recommended in the 2009 Australian Evidence-Based Guidelines for the Nutritional 
Management of Adult Kidney Transplant Recipients to manage hypertension.14 Sodium 
intake recommendation of 1300–2300 mg is recommended for the general population in 
the absence of hypertension.66  
 
Potassium intake of 4700 mg daily is recommended in post kidney transplant 
recipients,76 as in the general population66 and would be restricted to 1000–3000 mg in 
hyperkalemia, hypercalcemia and/or oliguria.16 As with sodium, serum potassium can be 
elevated with the use of CNIs and thus would necessitate potassium restriction.77  
 
Calcium recommendation is 1000–1500 mg/day with supplementation as 
necessary76 which is similar to recommended adequate intake of 1000 mg per day. A 
recommendation of 1200–1500 mg daily of phosphorus is noted16 and is higher than the 
adequate intake amount of 700 mg recommended for the general population.66 
Hypophosphatemia is an issue in the early post transplant period due to phosphaturia16 
and is seen in about a fourth of recipients with proper allograft functioning, sometimes 
requiring supplementation of dietary phosphorus. Magnesium recommendations are 200–
300 mg daily15 may need to be supplemented in the diet.76 This is lower than the 
recommended daily intake of magnesium for males (400–420 mg) and females (310–320 
mg) in the general population.66 
 
For the prevention of long-term complications associated with post-transplant 
recipients such as excessive weight gain leading to obesity, hyperglycemia, hypertension, 
hyperlidemia, hypercholesterolemia and osteoporosis, goals of care would target these 
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co-morbid conditions. To tailor caloric needs to the individual to attain or maintain 
desirable weight, calories would need to be adjusted. Protein recommendations would be 
0.8 to 1.0 g protein/kg body weight, based on serum albumin levels and assessment of 
patient status. Carbohydrate intake of simple sugars is discouraged to maintain blood 
glucose and avoid weight gain. Dietary fiber of 25–30 g/day is encouraged to assist in the 
maintenance of blood glucose and cholesterol levels and in the prevention of excessive 
weight gain. Limiting fat intake to 30% or less with 10% or less saturated fat, 10% 
polyunsaturated fat and the rest from monounsaturated fats in accordance to the 
American Heart Association (AHA) guidelines for Americans would help with 
maintaining cardiovascular health while also limiting cholesterol intake to 300 mg 
daily.76  
 
Fluid and electrolytes, as well as vitamins and minerals should be tailored to the 
individual as previously discussed in the early transplant period. Restriction or 
supplementation would depend upon monitoring serum levels of these nutrients on a 
regular basis post-transplant. 
  
 
Macro Nutrient Intake Post Kidney Transplant 
 
 Very few research studies report the micro-and macro nutrient intake following 
kidney transplantation. A cross-sectional study by Pulgar and colleagues17 reported the 
macronutrient intake in 119 (56% males) kidney transplant recipients from eight states of 
Mexico attending the Mexico National Olympiad. Macronutrient consumption obtained 
through 24-hour dietary recall was analyzed for nutrient composition using the e-dossier 
nutrition program.  
 
In Mexican states that border the United States of America (USA), BMIs were 
higher (≥ 25 kg/m2) among those transplant recipients compared to BMIs in states in 
Mexico that do not border the USA. Significantly higher ingestion of proteins and lipids 
than recommended DRIs (p < 0.05) was also demonstrated in these border line states in 
Mexico than in other states in Mexico. Of the states showing higher intake of proteins 
and lipids, the state of Nuevo Leon had the highest intake of percent fats (30.22 ± 0.8) as 
compared to recommended 25.6 ± 0.7. Researchers suggested that these results could be a 
reflection of the industrialized nature of the states bordering the USA and mirroring the 
USA’s dietary intake practices.17  
 
 In a prospective study during the first year following kidney transplantation, 
Haggan and colleagues investigated outcomes of nutritional markers and body fat 
composition in 44 post kidney transplant recipients. A dietary protocol of 30 to 35 
kcal/kg/d and 1.3 to 1.5 g/kg/d of protein recommended during the first 3 months 
following transplantation. Fat intake was suggested at < 30%, cholesterol intake was 
restricted to < 300 mg/d and simple sugars were restricted from dietary intake. 
Participants completed a 3-d food record, recording all foods consumed.78 All 
participants in the study,78 had a mean energy intake of 29.6 kcal ± 7.5 and a protein 
intake of 1.1 g ± 0.4. The dietary intake of energy and protein steadily increased to the 6 
month time point (32.6 kcl ± 7.2 and 1.36 g ± 0.33) and stabilized at 1 year (31.7 kcal ± 
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6.4 and 1.33 g ± 0.31). Weight loss and a decrease in fat mass were seen by these 
researchers in male recipients, suggesting that nutrition/dietary recommendations could 
have a positive influence on weight gain post transplant.78 
 
 
Dietary Reference Intakes (DRIs) 
 
 The term Recommended Dietary Allowance (RDA) is the former label used for 
standards of gauging nutritional sufficiency since 1941. The current term, DRI, was 
introduced in 1997 replacing RDA in the United States.79 Developed by the National 
Academy of Sciences’ Institute of Medicine (IOM) of the United States Agricultural 
Department (USDA), along with the government of Canada, DRIs also replace 
Recommended Nutrient Intakes (RNIs), formerly used by Canada.79 
 
DRIs, the current method of depicting reference standards related to identified 
nutrients, include the previously used term RDA, along with the three other distinct 
reference values. The four reference values included in the new DRIs are the estimated 
average requirements (EAR), recommended dietary allowance (RDA), adequate intake 
(AI) and tolerable upper intake level (UL). These four values can be used when planning 
interventions for individuals and groups, as well as assessing dietary intake of these 
entities. The advantage of having four reference values, as opposed to one reference 
value (i.e., RDA), is that varied types of reference values can be applicable to 
recommended nutrient intake for either individuals or groups.79  
 
Most nutrients have EAR which have been established, as well as a corresponding 
RDA, related to the EAR. If there is no established EAR, a related RDA has been 
identified. In the case of no DRI (and thus no RDA), an AI has been determined. Other 
nutrients have UL which have been established as the tolerable upper limit for that 
nutrient to be acceptable.79  
 
All of the DRIs represent an average of the daily nutrient intakes, similar to the 
previously used RDAs and RNIs. This new set of four distinct DRIs now represents a 
distribution of nutrient requirements as opposed to a single number.80 
 
The first of these reference values is the Estimated Average Requirement (EAR). 
This takes into account the daily projected nutrient intake quantity required by 50% of 
healthy individuals accounting for gender and life stage.79 The second reference value, 
RDA is developed from the EAR and is the dietary nutrient level needed on a daily basis 
to fulfill the nutritional needs of almost all healthy persons (i.e., 97-98%), in order to 
prevent or decrease the development of chronic disease. The RDA accounts for variation 
in nutrient requirements within certain groups (i.e., males, females, children, persons over 
70 years and lactating females). The third reference value is the Adequate Intake (AI). 
This quantity is used when an RDA for a particular nutrient has not been determined 
through research. It is used to establish goals for individuals to prevent chronic disease, 
for example, to decrease fat intake for adults or to sustain a component of desired health 
such as retention of calcium in bones.79 Finally, the Upper Limits (UL) reflects the upper 
or highest level of average intake for a nutrient that will not create undo risk of 
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unfavorable health issues in healthy individuals in the population. Intake levels exceeding 
the UL could pose health risks.79 
 
 
24-hour Dietary Recall 
 
 Several methods for collecting dietary intake data include food frequency 
questionnaires (FFQ), diet histories, food record method and the 24-hour dietary recall. 
The method used depends on the type of data needed. Advantages of 24-hour dietary 
recall and the food record methods are that actual amounts of food and fluid consumed by 
participants are reflected. Twenty-four hour dietary intakes and food records are 
considered more accurate methods of assessing dietary intake as opposed to the FFQ and 
diet histories.81 
 
This current study used the 24-hour dietary recall method, the most widely 
employed method of obtaining dietary intake data in the United States. This method has 
been used by the National Center for Health Statistics for collection of dietary data for 
the three National Health and Nutrition Examination Surveys (NHANES): NHANES I 
(1971-1975), NHANES II (1976-1980) and NHANES III (1988-1994) and for NHANES 
Hispanic subgroups.81,82 In addition, the 24-hour recall method has been used by the U.S. 
Department of Agriculture Surveys and in clinical trials with nutritional components.81  
 
There are other advantages of the 24-hour dietary recall as opposed to other 
methods of collecting dietary intake data. Historically, the 24-hour dietary intake method 
has been done in a face to face interview format with participants. More recently, 
telephone interviews have become a common method of collecting dietary intake. The 
two advantages of telephone interviews are apparent. The first advantage is that the 
telephone precludes the need for the participant and interviewer to meet at a designated 
location. This is especially useful when multiple days of dietary intake are obtained, as in 
this study. The second advantage is that the interview can be done on a day that is 
unexpected or unannounced to the participant, in the hope that their eating habits will not 
be altered by the anticipated recall.81 
 
Although there are advantages in telephone interviews when collecting 24-hour 
dietary intake, there are some disadvantages. One disadvantage of collecting dietary 
intake using telephone interview is the lack of ability to show pictures of food or to use 
food models for participants to estimate food portion size. Other disadvantages to this 
method are similar to those of face-to-face interviews including inaccurate reporting of 
foods eaten and inability of participants to remember food intake from the previous day. 
The interview situation could also lend itself to a potential bias in the responses of the 
participants.83  
 
 The collection of dietary intake data using the 24-hour dietary recall method is 
subject to a degree of error.84 However, the error of data collection using the 24-hour 
dietary recall method can be reduced. The main source of error in data collection is the 
participant’s memory. Skillful interviewers using prompting and probing questions 
related to the participant’s preceding 24-hour dietary intake can assist participant’s recall 
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of consumed food and fluid in the preceding 24-hour period. This can be accomplished in 
part, by relating food intake to activities done during the previous day. A list of 
commonly forgotten items such as candy, cookies, chips and drinks can also assist 
participants to more accurately recall intake.81,85 
 
 Underreporting, another source of error of 24-hour recall of dietary intake, can 
occur but may be reduced if participants are thoroughly briefed on the process of the 24-
hour dietary recall method. The use of a multiple-pass system allowing the interviewer to 
use a hierarchical system while gathering more detail with each pass lessens 
underreporting when gathering dietary intake data.81 Multiple-passes also allow the 
interviewer to obtain more detailed descriptions of foods, lessening inadequate 
description of foods as another source of possible error.85 
 
 The day- to-day variation in dietary intake in participants is a source of random 
error, which is a part of dietary intake measurements. The multiple-pass approach, along 
with multiple days, help to lessen this degree of error when gathering dietary intake 
data.85  
 
Another key aspect of gathering accurate dietary intake is the interviewer’s 
emphasis on the importance of the participant’s assistance to the research. It is necessary 
for the interviewer to stress the value of their contribution to the research study.81 
 
 Another source of error for the 24-hour dietary recall method is the estimation of 
portion sizes by participants. This type of error can be reduced by the use of standardized 
household measures such as teaspoons, tablespoons and cups and by estimating portion 
sizes in three dimensions using inches.81 
 
 Finally, the motivation of the participants to accurately describe details necessary 
for a thorough 24-hour dietary recall can be a source of error. The establishment of 
rapport in a professional, nonthreatening manner, where participants feel free to respond, 
can be a motivating factor for participants to more accurately respond to the interviewer. 
Incentives to participants, such as money and the knowledge that they are contributing to 
research, might also increase motivation.81 
 
 
Reliability and Validity of 24-hour Dietary Recalls 
 
 A study conducted to assess the accuracy and precision of four different types of 
dietary intake collection were compared in a small cohort of healthy young women (n = 
20) and older women (n = 20). Food intake data was collected using 24-hour recalls, 7- 
day weighed food intake data and food frequency questionnaires (FFQs) and 2 previously 
validated FFQs. These four food consumption records were compared with total energy 
expenditure (TEE) using doubly labeled water. The participants drank the doubly labeled 
water and collected urine specimen for 8 days. 
 
 Results showed that of the four methods used, 24-hour recall method was more 
congruent with TEE in younger women and that one of the FFQs, Willett FFQ, was 
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closest for energy intake to TEE in older women. In this study, the more complex method 
of 7-day weight dietary intake was no more precise than the other less complex methods. 
Researchers concluded that although these dietary intake methods are considered suitable 
for measuring energy intake, that further studies need to be done to determine accuracy of 
these dietary intake assessment methods.86 
 
 Another study evaluating 24-hour recalls as compared to four-day food records, 
reported that unannounced 24-hour recalls were the preferred method of collecting 
dietary intake data as opposed to the 4-day food record. Although underreporting can be 
present in all types of dietary intake data, these researchers suggest that through the use 
of skilled interviewers asking probing questions, underreporting can be decreased. Their 
data showed a relatively low level (8%) of underreporting which they attribute to the 
manner in which their trained interviewers conducted the dietary recalls.87 
 
 A more recent study in Brazil using healthy women (n = 65) between the ages of 
18 and 57 years comparing FFQ, food records and 24-hour recalls using doubling labeled 
water, showed similar results. Less underreporting of energy intake was seen using the 
24-hour dietary recalls and food records as compared to FFQ method.88 
 
 
Nutrition Data System for Research (NDS-R) 
 
The NDS-R was developed by the Nutrition Coordinating Center (NCC) at the 
University of Minnesota in Minneapolis in 1974.89,90 In collaboration with the National 
Heart, Lung and Blood Institute (NHLBI), the data system software was developed and 
used for two research programs at its inception. This led to the establishment of the 
Nutrition Coordinating Center (NCC) by the National Institute of Health (NIH), which 
continues to be a renowned national center for research at the University of 
Minnesota.89,90 Since then, the system has continued to change and grow into a 
comprehensive research database used by hundreds of institutions in the United States as 
a research instrument.90  
 
The NDS-R is maintained by the NCC at the University of Minnesota and is 
updated on a regular basis in order to reflect current foods consumed in the United States. 
Ethnic foods as well as specific age group populations are included in the comprehensive 
database.89,90  
 
 The comprehensiveness of this food and nutrient database is demonstrated by the 
number of foods and food brands in the system. Currently, the NDS-R contains over 
18,000 foods and 7,000 brands of food products. Prepared foods with ingredient choices 
number more than 160,000 foods.91  
 
 A major part of the database is the nutrients contained in food. The nutrient list 
currently contains 160 nutrients. Ratios of nutrients and other components related to food 
such as energy sources, fat and cholesterol, carbohydrates, fiber, vitamins and minerals 
are included. Other food components more recently added are carotenoids. Sugar alcohol, 
amino acids, isofavones and other food components are a part of the system.91  
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 Another important feature of the database is the assignment of foods to food 
groups, including fruits, vegetables, grains, dairy and alternatives, meats and meat 
alternatives, fats, sweets, beverages and miscellaneous foods. These food group 
assignments are further delineated into 166 subgroups.91 
 
 Still another feature that makes this database attractive to researchers includes the 
standardization of the system using published imputation. For example, to have a 
complete nutrient database, it is sometimes necessary to impute or calculate values from 
similar foods as in ingredients in frozen dinners and the nutrients in each ingredient. This 
can be done in a variety of ways including using values from a similar food or a different 
form of the food, using calculations from recipes or nutrition labels, to name a few.92 
 
 Finally, updates to the system are made annually and released to licensed users. 
These updates reflect many changes in the current food market. Analytic data is also 
improved with each annual update.93  
 
 Specific studies when using NDS-R can design study specific protocols when 
there is a questionable food or amount to enter into their data. These data entry rules are 
established and recorded by the research team and made available to those collecting and 
entering data. This information lends itself to more valid and reliable data entry since 
consistency among team members are established.93  
 
 To meet the need for stability of nutrient database, several versions of the Food 
Table remain available. Even with updates, the users for long term studies will have the 
nutrient values determined for foods when the consumed foods were reported. At the end 
of the study, investigators can determine to use the original nutrient content or the 
updated versions as necessary.94  
  
 In order to evaluate validity and reliability, quality control measures to verify data 
entry of various food sources, need to be part of a data system.92 Suggestions for quality 
control include reviewing the system’s manual, editing any improperly entered data, or 
data in error. Other quality control measures include consistency of the program among 
the nutrient values of foods that are similar and consistency of nutrient contents within 
foods. These are automatic in NDS-R. Data consistency is also maintained by comparing 
nutrient values to algorithms of expected food values.92 If discrepancies are found 
between the calculated algorithms, and what is contained in the database, nutrient ranges 
are flagged and investigated by NCC personnel. 
  
 Another demonstrated means of maintaining validity and reliability includes the 
standardized method of interviewing prompts that are included to guide the dietary recall 
interview on various screens in the software. This method uses the feature of direct data 
entry using an interactive process.95  
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 Another measure to ensure validity and reliability is NDS-R’s multiple-pass 
method of obtaining the participant’s recall. This gives the researcher four occasions to 
gather information for accuracy and completeness as previously discussed.95  
 
 Still another means of validity and reliability is demonstrated by the number of 
reviews of the data. The first review is with the participant, second is when the 
investigator reviews the data following the interview and thirdly by confirming amounts 
on any data entry errors.95 Standardization of food portions using household measures 
such as cups and teaspoons/tablespoons increase validity and reliability of the data 
received and entered.  
  
To further discuss validity and reliability, it is imperative that users of NDS-R 
have documentation regarding how nutrients are calculated and the sources of 
information used for this dietary data. The coding system in NDS-R designates the 
reference source including the page number or a specific code from the source. Examples 
of sources for nutrient data include the United States Department of Agriculture (USDA) 
reference, scientific journals, food tables and other sources in which nutrient data can be 
obtained. Researchers can determine the reliability of the nutrient data by the sources of 
the data used in the food tables provided.94 
 
 In an ongoing attempt to maintain accuracy of the data base to maintain reliability 
of data, NDS-R developers employ several methods of quality control to achieve this. 
These include updating NCC Food Table on daily basis allowing for modifications in 
nutrients. Another way includes periodic checks of accuracy for the “Reference Food 
Table” by reviewing the algorithms used for calculations of nutrients for any deviations. 
Finally tests can be done to check various calculations and compare to previously 
calculated test records for nutrient values.94 
 
 Finally, inter-study comparability is also possible with NDS-R, which allows 
investigators to compare nutritional data between studies done in the past and in the 
future. Even foods that are no longer available on the market are maintained in the 
database. Recalculated values as updates occur can be compared to older versions of the 
food product.  
 
In order to evaluate validity and reliability, quality control measures to verify data 
entry of various food sources, need to be part of a data system.92 Reviewing the system’s 
manual, editing any improperly entered data, or data in error, consistency of the program 
among the nutrient values of foods that are similar and consistency of nutrient contents 
within foods are automatic quality control features in NDS-R. Data consistency is also 
maintained by comparing nutrient values to algorithms of expected food values.92 If 
discrepancies are found between the calculated algorithms, and what is contained in the 
database, nutrient ranges are flagged and investigated by NCC personnel. Still another 
means of validity and reliability is demonstrated by the number of reviews of the data. 
The first review is with the participant, second is when the investigator reviews the data 
following the interview and thirdly by confirming amounts on any data entry errors.95 
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Standardization of food portion visuals, graphic paper and food amounts booklet using 
measurements also increase validity and reliability of the data received and entered. 
 
Reliability and validity of the NDSR has been well established. Since its inception 
in the 1970’s, the database has been used in many clinical investigations for analysis of 
dietary intake. Its use has been identified in trials related to cancer, cardiovascular disease 
and hypertension, and in gastrointestinal and bone health disorders.89 
 
 
Physical Activity in Kidney Transplant Recipients 
 
 Along with nutritional management, physical activity and conditioning play a role 
in the prevention of secondary complications (i.e., obesity) following kidney 
transplantation. Kidney transplant recipients generally show an improved capacity for 
activity and exercise as compared to their pre-transplant level.25  
 
 
Health Benefits in Kidney Transplant Recipients 
 
 Physical activity on a regular basis following kidney transplant is important for 
several reasons. The possibility of minimizing weight gain while lowering risks of co-
morbidities such as cardiovascular disease and diabetes is of primary importance.77 
Improvement in quality of life and feelings of well being are also desirable.96  
 
 However, conditions developing prior to transplantation, such as fatigue and 
muscle de-conditioning leading to weakness, are obstacles for physical activity. Poor 
motivation for physical activity many also be a barrier.96,97 
 
 Following kidney transplantation, cardiac output may be reduced due to a number 
of reasons such as cardiomyopathies, which could limit some types of activities such as 
aerobic exercise.96 Blood pressure is also affected in kidney transplant recipients due to 
denervation of the transplanted kidney, so blood pressure could be higher in these 
individuals following exercise.98 
 
 To illustrate these cardiovascular issues, researchers employing a prospective 
research design tested exercise capacity in 16 kidney transplant recipients for 2 years 
following transplantation. Peak oxygen consumption (VO2 max) was significantly lower 
in the transplant recipient group compared to the healthy control group at 1, 4 and 10 
months but not at 16, 24 and 48 months. VO2 max did not show improvement in these 
participants after 16 months. The reason for this decrease in VO2 max was thought to be 
the adverse correlation of VO2 max with resting systolic blood pressure prior to exercise 
(r = -0.26, p ≤ 0.039), suggesting a lack of normotensive parameters in the sample. 
Echocardiographic structural changes and VO2 max were negatively correlated with 
diastolic diameter of interventricular septum (r = -0.37, p ≤ 0.004) and systolic diameter 
interventricular septum (r = -0.38, p ≤ 0.003). Negative correlations were also seen in left 
ventricular end-systolic volume (r = -0.49, p ≤ 0.043) and VO2 max. These researchers 
conclude that exercise capacity of post kidney transplant recipients is lower than healthy 
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controls and suggest future studies of a larger prospective nature to see if permanent 
improvement of cardiovascular issues and exercise capacity can be achieved with these 
transplant recipients.99 
 
 In another prospective study designed to follow 32 kidney transplant recipients 
for 5 years, researchers administered two validated questionnaires through interviews, the 
Baeche and the Five City Project 7-day recall to post kidney transplant recipients. These 
participants were interviewed about their pre-transplant physical activity about 15 days 
after transplantation. They were also interviewed using the two instruments at 1, 3, 6 and 
12 months following transplantation. Due to participant loss to follow-up, only 18 
participants were available to interview at the 5-year time point.20 
 
 These researchers found that compared to healthy controls, the transplant 
recipients were significantly less active and scored between 18% and 35% lower at the 
pre-transplant interview. However, physical activity showed a significant increase within 
the first year in these transplant recipients and showed ~ 30% mean physical activity 
level increase which was significantly different from pre-transplant physical activity 
levels.20 
 
 
7 Day-Physical Activity Record (7D-PAR) 
 
 This study used the 7 Day-Physical Activity Report (7D-PAR) to assess physical 
activity at baseline and at three and six months following kidney transplantation. The 7D-
PAR is an instrument for gathering self-reported physical activity recall from participants 
through the use of interview, either face to face or per telephone. Moderate, hard or very 
hard exercise performed continuously for at least ten minutes is recorded. Time spent in 
light activities and sleep is recorded for the previous seven days.100 
 
 When classifying activities by their required energy, the term of metabolic 
equivalent (MET) is used. This method of describing energy expenditure takes into 
account the ratio of working to resting metabolic rate. Activities are classified and 
assigned a number according to their MET as follows: sleep – 1 MET; light activity – 
1.0–2.9; moderate activity – 3.0–5.0; hard activity – 5.1–6.9 and very hard activity – 
>7.0.100 
 
 Some difficulties have been identified with use of the 7D-PAR. First, interviewers 
need to be trained in the use of the 7D-PAR to gather data and to classify the METs for 
activities. Second, the time required per interview is approximately twenty minutes and 
may discourage its use with some researchers. Last, as with any self-reported data, the 
participant’s ability to recall the previous seven days of activity, along with ambiquity of 
certain activities, may be an issue. However, use of the 7D-PAR with populations can 
characterize their activity levels, requires an acceptable amount of time to gather data and 
is appropriate for use in studies to gain knowledge about a particular study group.100 
 
 Various studies have examined the validity of the 7D-PAR. Test-retest reliability 
using 64 participants showed a Pearson correlation of r = 0.83, (p < 0.0001) between 
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amount of reported vigorous activities. More variability was seen in Pearson’s correlation 
in moderate activity (r = 0.75, p < 0.0001). Reliability coefficients varied for other 
components but these researchers reported stable means during the 2 week testing 
interval. Reported factors possibly attributing to these variations in reliability coefficients 
were gender and being overweight. Reliability of reporting energy expenditure was 
higher in males than females, demonstrated by Pearson’s correlation.100 
 
 Criterion validity, along with reporting error factors, was examined in a 
moderately overweight group of young adult, both male and female, using doubly labeled 
water (DLW) with healthy controls. Two measures from the 7D-PAR, total daily energy 
expenditure (TDEE) and physical activity energy expenditure (PAEE), were compared to 
the healthy controls of young adults using doubly labeled water. The 7D-PAR and DLW 
were used to calculate PAEE. Significant differences in TDEE were not found between 
the 7D-PAR and DLW. No significant difference was found in mean PAEE from 7D-
PAR and DLW. These data show that mean TDEE and PAEE were reliable estimates for 
group means but may not be reliable for calculation of individual PAEE.101 
 
 Another means of evaluating reliability and validity of self reported data from the 
7D-PAR was compared with data from triaxial accelerometer (RT3) during July 2002 and 
August 2004 in a random clinical trial. One hundred thirty-nine recent breast and prostate 
cancer survivors participated in a diet and exercise intervention. Moderate agreement 
between the 7D-PAR and accelerometer was demonstrated at baseline (r = 0.54), 1 year (r 
= 0.24) and 2 years (r = 0.53) with all p values < 0.01. For moderate-to-vigorous physical 
activity, estimates were higher with the accelerometer. These data show modest 
agreement between self-reported physical activity and accelerometer.38  
 
 
Compendium of Physical Activities 
 
 The Compendium of Physical Activities originally developed by Ainsworth and 
colleagues47 in 1993 is a coding method for physical activities. Self- reported physical 
activity data surveys, as well as physical activity logs and records, can be coded for use in 
observational studies. A five digit code represents certain physical activities of different 
intensities using metabolic equivalent intensity level (MET). Resting metabolic rate when 
an individual is sitting quietly is representative of one MET. The Compendium contains 
lists of activities that are multiples of this resting MET state. For example, sleeping is 
represented by 0.9 while running at 10.9 miles per hour is designated by 18 METs. The 
updated Compendium includes a supplementary list of activities representing suggested 
additions from researchers over the past ten years. Various other types of daily activities 
and their MET values have been added to the Compendium to represent interests of 
public health research.37  
 
 
Value and Limitations of Using the Compendium 
 
 When using the Compendium for research, it is important for investigators to 
record only the time the participant spends in actual movement when energy costs or 
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METs are measured. The original intent of the Compendium was not to measure absolute 
energy requirements of certain activities, but instead, proposes a means of classifying 
physical activities in a standardized manner so that MET intensities could be estimated.37  
 
 A limiting factor to the Compendium is that factors such as age, gender, body 
types and body fat compositions are not considered. Other factors such as environment 
and ease of bodily movements are not accounted for in individual differences when 
calculating MET levels. Some activities contained in the Compendium are not based on 
indirect calorimetry. Similar activities may have similar MET values giving altered 
confidence levels around mean MET values for those activities.37 
  
 
Immunosuppression following Kidney Transplantation 
 
 Adequate immunosuppression is crucial to maintaining the new transplanted 
kidney. The balance is a delicate one, preventing rejection of the allograft while avoiding 
the effects of over-suppression leading to infections, cancers and side effects, such as 
nephrotoxicity, that could threaten the transplanted kidney.102 Along with preserving the 
newly implanted kidney, another goal is to decrease the long-term side effects of 
immunosuppressant medications. The benefits, compared to the risks of chronic steroid 
administration, are being questioned, causing a paradigm shift to steroid taper regimens 
or steroid free protocols used in some practices.103 
 
 Immunosuppressant medications currently used in clinical settings are described 
as using a T-cell activation and proliferation model. This model is made up of three 
signals causing T cells to activate. During the first signal, T-cell receptors are triggered 
by antigen-producing cells (APCs) causing a specific antigen signal which leads to the 
antigen being transduced through the CD3 complex.41  
 
 The second signal results in secretion of interleukin-2 (IL-2) and other cytokines. 
This is caused by the interaction of B7 on the APC and CD28 on T cells. Activation of 
mammalian target of rapamycin (mTOR) is achieved through stimulation of the IL-2 
receptor (CD25). This second process causes the third signal to initiate leading to cellular 
proliferation.41 
 
 Immunosuppression is represented by two distinct phases known as induction and 
maintenance. At the time of transplantation, or during induction, monoclonal or 
polyclonal antibiotics are used targeting specific processes in the immune system. The 
maintenance phase continues during the recipient’s life and usually consists of a 
combination of medications including corticosteroids, calcineurin inhibitor (CNI) and 
antiproliferative agent.24 
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Dietary Aspects of Immunosuppressant Medications Affecting Weight 
 
 Although the use of immunosuppressant medication is vital to the preservation of 
the new implanted kidney, these medications have side effects. One of the possible side 
effects of corticosteroids and immunosuppressant medications is weight gain.  
 
 Corticosteroids or glucocorticoids, directly affect carbohydrate metabolism. 
Blood glucose concentration in the blood is caused by gluconeogenesis in the liver. At 
the same time, blood glucose is increased, uptake of glucose into other cells such as 
muscle, adipose and lymphatics is decreased. This decrease use of glucose peripherally 
and an increase blood glucose causes insulin to be secreted. These glucocorticoids also 
increase appetite and promote fat deposits in the face and neck area.104  
 
Corticosteroids have been used for over 40 years in immunosuppressive regimens. 
However, some centers are now tapering steroids in the early transplant period while 
others are employing steroid free protocols. 
 
 Corticosteroids used over long periods of time have side effects that are well 
documented.  Side effects such as weight gain, hypertension, hyperglycemia, and post-
transplant diabetes, along with increased blood lipid levels, impact cardiac co-morbidities 
following kidney transplantation. Muscle wasting affects could also impact physical 
activity following kidney transplant.24 
 
 Several classifications of immunosuppressant medications are currently used in 
clinical practice. These include corticosteroids, calcineurin inhibitors (CNIs), mTOR 
inhibitors and antiproliferative agents. 
 
 The CNIs prevent the synthesis of interleukin (IL)-2. Common to the kidney 
transplant recipients in this study is tacrolimus, a CNI which binds to proteins inside the 
cells of cyclophilin (FK-binding protein). This intracellular binding process leads to 
inhibition of IL-2 mediated T cell activation and prevents proliferation of lymphocytes.24  
Posphatase activity is inhibited by the resultant drug-protein complex leading to 
diminished IL-2 synthesis.105  
 
 Because tacrolimus (Prograf) is metabolized by the cytochrome P450 enzyme 
system in the liver, the possibility of drug and food interactions can occur. For example, 
grapefruit or grapefruit juice are known to reduce or inhibit the P450 system, thus 
changing levels of CNIs metabolized by the same metabolic pathway in the liver.24 
 
 Tacrolimus has other side effects such as posttransplant diabetes, hypertension, 
hypomagnesemia and hyperkalemia. Magnesium supplements and low potassium diet are 
used to treat these electrolyte imbalances following kidney transplantation.24 
 
 The mTOR inhibitor, sirolimus, has a different mechanism of action than the 
CNIs. The binding of sirolimus to calcineurin at the FK binding protein then binds 
mTOR interfering with cell replication at the G1 to S phase. Metabolism of sirolimus also 
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occurs in the cytochrome P450 system, making drug-food interactions as stated earlier 
with CNIs a potential issue.24 
 
 Side effects of sirolimus having dietary implications include alterations in 
triglycerides and cholesterol. Diarrhea and other gastrointestinal disturbances can also 
impact dietary intake and absorption of nutrients from dietary intake. Modification of 
diet, use of antilipid medications and omega-3 fatty acids (fish oil) have been useful in 
the treatment of lipid abnormalities associated with the use of sirolimus.106 
 
 Finally, the last classification of immunosuppressant medications prescribed to 
participants in this study are the antiproliferative agents, namely MMF (Cellcept). The 
active compound in MMF is mycophenolic acid (MPA) which inhibits an enzyme, 
inosine monophosphate dehydrogenase (IMPDH). IMPDH affects the denova synthesis 
of purine affecting production of quanosine nucleotides from quinine. This action in turn 
has antiproliferative effects on lymphocytes which rely on denova synthesis of proteins. 
It has no effect on cytokine production, unlike calcineurin inhibitors and sirolimus.107 
 
 Side effects of MMF that would impact nutrition are nausea and diarrhea. 
Recipients on MMF experiencing gastrointestinal symptoms could have poor dietary 
intake resulting in decreased kilocalories and weight loss. These side effects can be 
lessened by reduced dosage and shortened intervals between doses.24 
 
 The potential dietary interactions of these medications require monitoring 
following kidney transplantation. Dietary issues present prior to transplant should be 
addressed. Follow-up after kidney transplantation should address potential issues such as 
weight gain and other side effects mentioned that could affect dietary intake in the 
months following transplantation. 
 
 
CNIs Affecting Weight Gain following Kidney Transplantation 
 
 A retrospective study of 99 kidney transplant recipients between 1988 and 2006 
assessed the effects of two types of calcineurin inhibitors on weight gain following 
kidney transplantation. The first group of recipients received cyclosporine A (CyA), 
while the second group was prescribed tacrolimus (Tac). Both groups received 
prednisolone  in addition to either Cya or Tac, and either mycophenolate mofetil (MMF), 
azathioprine or interleukin-2 receptor antagonists. Prednisolone was progressively 
reduced at the first, second and sixth months. Weight gain was statistically significantly 
increased (p < 0.01) after six months. Twelve month weight gain was 3.8 kg ± 6.8 kg in 
the Tac group and 8.7 kg ± 7.8 kg in the CyA group. Although both groups gained 
weight, more weight was gained by the group using CyA which suggests that the type of 
immunosuppression could affect the amount of weight gained following kidney 
transplant.108  
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Summary of the Chapter 
 
 In summary, weight gain is an issue in the general population and in kidney 
transplant recipients following transplantation. Evidence-based information is 
documented regarding the health outcomes in the general population and some research 
done in post kidney transplant recipients report similar co-morbidities related to weight 
gain. A body of knowledge is lacking in the dietary intake practices of individuals 
following kidney transplantation. Weight gain is pronounced in the first year following 
kidney transplantation with a slower trajectory of weight gain after the first year 
following transplantation. Studies suggest that increased calorie intake without 
concomitant increase in physical activity lead to weight gain in these individuals. Even 
though some physical activity investigations have been done, intervention studies 
designed along with prescriptive dietary interventions could impact the amount of weight 
gain in these individuals. As per the findings in some of the studies in the review, 
immunosuppressant medications may also play a role in weight gain following kidney 
transplantation, but the evidence is not clear as to which medications affect weight gain 
in individuals post transplantation.  
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CHAPTER 3. METHODOLOGY 
 
 
Research indicates that weight gain leading to obesity following kidney 
transplantation is a significant problem. Relationships between weight gain and co-
morbid diseases have been established. Factors including increased dietary intake, low 
physical activity and immunosuppressant medications have been suggested as the cause 
of weight gain. However, there is little data documenting dietary intake and physical 
activity of kidney transplant recipients. Thus, this study set out to characterize micro and 
macronutrient intake and physical activity in persons following kidney transplantation. In 
addition, this study determined if associations exist between dietary intake, physical 
activity, immunosuppressant medications and weight gain following kidney 
transplantation. This chapter describes the methodology of this study including research 
design, setting, sample, and procedures. 
 
Research Design 
 
A descriptive, correlational study included secondary data to examine dietary 
intake, physical activity, and other factors (e.g., age, gender, race, and 
immunosuppressant medications) associated with weight gain following kidney 
transplantation. All participants were enrolled in a larger 5-year, prospective longitudinal 
study examining genetics (expression profiles), environmental factors (e.g., dietary intake 
and physical activity) associated with weight gain leading to obesity following kidney 
transplantation. Dietary intake and activity recalls were done via face to face interviews 
in the university hospital’s kidney transplant clinic or by telephone interview at baseline, 
three and six months. Clinical data were obtained through the university hospital’s 
electronic records or by charts located in the transplant clinic. 
 
 
Sample 
 
 This secondary data analysis provided examination of dietary intake, physical 
activity and other variables (e.g., age, gender, race, immunosuppressant medications) 
associated with weight gain post kidney transplant. After obtaining institutional review 
board approval, dietary intake, physical activity and clinical data were used from 
participants enrolled in a larger, 5 year longitudinal study exploring environmental and 
genetics factors and their association to weight gain and obesity after kidney 
transplantation. The participants in the parent transplant obesity study were transplanted 
between August 2007 and August 2009 at a large Midsouth university-hospital-based 
transplant institute. The inclusion criteria for the parent study included 18 years of age or 
older, must be able to read and understand English. Exclusion criteria for the parent study 
included receiving steroid therapy prior to the time of transplantation. 
 
Forty-eight participants who had reached their 6 month time point and had 
baseline, 3 and 6 month dietary, physical activity and weight data were considered for the 
secondary data analysis. Participants were excluded if they lost greater than 10% body 
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weight from baseline to 6 months. Blackburn and colleagues109 identified weight loss 
greater than 10% in a 6 month period as significant. This percent weight change usually 
accompanies poor oral intake or medical illnesses110 and indicates a state of protein 
malnourishment, impacting  immune functioning, morbidity and mortality.109 This study 
looked at dietary intake, physical activity and age, gender, race, and immunosuppressant 
medications and their association to weight gain, thus excluding the four participants who 
had lost greater than 10% body weight in the first 6 months following kidney 
transplantation.   
  
Four participants (1 African American male, 1 African American female, 1 
Caucasian male, 1 Caucasian female) were excluded because they had lost more than 
10% of their baseline body weight at 6 months. Thus, 44 participants (22 males and 22 
females) who had signed informed consent for the parent study and had reached their 6 
month time point since transplantation were included in this secondary data analysis.  
 
To minimize a threat to confidentiality, participant identification numbers were 
used. All data was password protected in a computer database. Consent forms were kept 
in a separate locked cabinet. Participant confidentiality was in compliance with the 
Health Insurance Portability and Accountability Act (HIPAA) guidelines for electronic 
data. Participants in the parent study had been informed about data collection, usage and 
storage to conform to HIPAA regulations. No other potential risks were identified. 
 
 
Setting and Recruitment 
 
A large teaching hospital located in the south eastern United States was the 
recruitment site for the larger parent study. Participants were recruited by core team 
members of the parent study either in the kidney transplant clinic or at various renal 
dialysis clinics. Consent forms were signed by the participants after a thorough 
explanation by core team members. Following approval by the university’s Institutional 
Review Board the principle investigator of the parent study provided deidentified data 
and the secondary data analysis was conducted.  
 
 
Procedures 
 
 For this study, dietary and physical activity data from baseline, 3 and 6 months 
post-transplant time points were used. Participants in the larger longitudinal prospective 
study had been informed of the various time points (baseline, 3 and 6 months) that dietary 
intake and activity recalls would be obtained. Most of the recall data were done per phone 
during regularly scheduled appointments in the transplant clinic. Twenty-four hour 
dietary intake was obtained at baseline and at 3 and 6 months following transplantation to 
include one weekend day and two weekdays of food and fluid. Seven-day activity recall 
interviews were done at baseline and again at 3 and 6 months post-transplant. BMI was 
calculated on all participants at their pre-operative workup visit to the clinic. Weight was 
measured at baseline and at the 3 month checkup and at the 6 month checkup using the 
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medical scales in the transplant clinic. Age, gender, race and immunosuppressant 
medications and other clinical data were obtained in the larger prospective longitudinal 
study by reviewing chart information in the clinic or by reviewing the electronic medical 
record.  
 
Dietary intake, physical activity data and clinical data were downloaded from the 
two databases where data had been entered for the larger longitudinal study. Dietary data 
from output files generated by NDSR were downloaded into a Microsoft Excel 
spreadsheet before exporting into Statistical Package for the Social Sciences, Predictive 
Analytic Software 18 for Windows™ (SPSS/PASW) version 18.0 (SPSS, Inc., Chicago, 
IL). Each nutrient variable of interest was maintained in the Excel spreadsheet. The 
physical activity data and clinical data were downloaded into a Microsoft Excel 
spreadsheet. Dietary intake, physical activity and clinical data were then merged into one 
single file for analysis of the variables of interest.  
 
Managing the data in the study, including data cleaning and preparation were 
necessary steps before data analysis could take place.111 Data cleaning of the dietary data 
involved inspecting each nutrient value for outliers in comparison to a reference DRI 
value. If extreme values for participants were found, verification of the data was made by 
reviewing the original data from the handwritten 24-hour dietary recall. After that, 
subsequent review of the data entry into NDS-R was performed to check for any data 
entry errors. If one or two days of the three days of dietary intake was present at a time 
point instead of all three days, means were imputed using the available data or a mean of 
the nutrient for the group was used for a missing value.112  
 
Physical activity data were downloaded from the storage database for the larger 
longitudinal study into an Excel spreadsheet before importing into SPSS for analysis. 
Cleaning the data involved inspecting for outliers and other irregularities. Any 
questionable data such as excessive amounts of physical activity were verified by first 
checking the original 7 D-PAR interview document where data were recorded and 
comparing it to data entered into the database for analysis. 
 
When creating the secondary analysis files, the names of the variables and the 
coding decisions were entered into an electronic codebook. Each variable was carefully 
named to ensure easy recognition of corresponding data in the spreadsheets when 
imported into SPSS. 
 
Once all of the data was in one spreadsheet, a second data cleaning was done to 
ensure that all measurements and time points were congruently entered into the original 
data. Because of data entry errors, weight entered into pounds was calculated into 
kilograms. In addition, errors in time point coding were corrected.  
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Instruments 
 
In this study, empirical data were obtained using the following approaches: (a) 
three day 24 hour dietary intakes entered into the Nutritional Data System for Research 
(NDS-R), (b) 7 Day-Physical Activity Record (7D-PAR) and (c) clinical data from 
transplant recipient chart reviews of electronic kidney transplant clinic records.  
 
 
Dietary Intake 
 
 3 Day 24-Hour Dietary Recalls 
 Dietary intake records consisted of 3 weekday recalls and 1 weekend recall. 
Participants were informed that each diet recall would take about 20-30 minutes in the 
larger longitudinal prospective study. The participants were contacted by phone regarding 
the dietary recall or interviewed face to face in the transplant clinic while awaiting a 
scheduled appointment. These unannounced dietary recalls were obtained using a multi-
pass prompted script interview. Participants were given three chances to give as much 
detail about the diet intake as possible. Diet data was verified by the investigator before it 
was entered into the computer. Data was analyzed by the NDS-R for Windows software 
into nutrient components including micro and macronutrient values. 
 
 The 24-hour dietary recall method employs an interview situation with trained 
research personnel to gather explicit information about a participant’s food and fluid 
intake for the previous 24-hour period. Probing questions are used to gather sufficient 
detail about the consumed dietary intake starting with the first time of the day that the 
participant had anything to eat or drink and progressing forward. The accuracy of the 24-
hour recalls is dependent upon the skill of the interviewer, as well as the memory of the 
participant about the previous 24-hour period.81 
 
 Validity of the 24-hour dietary recall method has been established through the use 
of this method in dietary surveys in the United States. Twenty-four hour recalls have 
been used to gather dietary diet in multiple government initiatives such as by the National 
Center for Health Statistics and the National Health and Nutrition Examination Surveys, 
as well as numerous large research studies.81 If describing the mean intake of a group is 
the purpose of the study, then a single 24-hour dietary recall is the appropriate method. 
Multiple days of dietary recall are considered by some experts to give more dietary 
information and is considered to be the gold standard when assessing the dietary intake of 
individuals. The one day, 24-hour recall can yield valuable data when obtained through 
prompting and clarification by the interviewer.113  
  
 Several strengths are associated with the 24-hour recall method. Because this 
method is based on actual reported intake, estimated intakes of kilocalories, and micro-
and macronutrient absolute values rather than relative values can be determined. 
Specificity of information is enhanced through the use of detailed descriptions of foods 
reported by the participants using a structured interview process. Details regarding foods 
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(e.g., sources, preparation method and amounts) can be obtained to answer research 
questions.  
 
 Another major strength of the 24-hour dietary recall method is that literacy issues 
are not a hindrance to the use of 24-hour dietary recall. Participants are not required to 
read or complete any written material.  
 
 The validity of this method is strengthened since it is generally an unannounced 
or unexpected event which lessens the chances of participants altering their dietary intake 
patterns.87 With 24-hour dietary intake recalls taking 20 to 30 minutes on average, 
participant burden is also decreased.81 
 
 Limitations of the 24-hour dietary recall method have been identified. A major 
limitation is that this method does rely on participant memory to call the previous 24-
hour food and fluid intake. Generally with this method, foods are not weighted or 
measured. The approach relies on the participants’ estimation of sizes and descriptions.81  
Limitations are discussed further in the limitations section in Chapter 4. 
 
NDS-R 
The use of computer software for data entry related to nutrition and dietary recall 
and its analysis of nutrients and other food components have aided nutrition research. The 
Nutrition Data System for Research (NDS-R), developed by the Nutrition Coordinating 
Center (NCC) at the University of Minnesota, is a Windows-based dietary analysis 
program used for entry and analysis of dietary intake. Considered the “gold standard” for 
dietary analysis, it contains data for 160 nutrients and food constituents, and is updated 
yearly to reflect changes in nutrient composition of foods and food market changes.90  
 
Features of NDS-R include the comprehensiveness of this food and nutrient 
database and the current nutrient list. These features are demonstrated by the number of 
foods and food brands exceeding 18,000 foods and 8,000 brands of food products. 
Prepared foods with ingredient choices number more than 160,000 foods.91 The nutrient 
list currently contains 160 nutrients. Ratios of nutrients and other components related to 
food such as energy sources, fat and cholesterol, carbohydrates, fiber, vitamins and 
minerals are included. Other food components more recently added are carotenoids. 
Sugar alcohol, amino acids, isofavones and other food components are a part of the 
system.91  
 
Reliability and validity has been established for NDS-R as a research database. It 
is a research tool extensively used by hundreds of institutions collecting and analyzing 
dietary intake.114 It has been used in a variety of clinical trials to calculate dietary intake 
data for various dietary-related diseases.89 When comparing four nutrient databases (e.g., 
ESHA Food Processor, NDS-R, Moore’s Extended Nutrient Database, and Nutritionist 
IV databases) with their chemical component data from a hypertension focus trial, the 
four nutrient databases, intraclass correlation between the sites of data entry was 0.998. 
Although some variance was noted among the four nutrient databases, it was small (< 
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10%) for some nutrients. Measures of bias and precision showed significant differences 
in some nutrients (e.g., kilocalories, saturated fatty acids, and polyunsaturated acids); 
their corresponding laboratory values had a variance of < 15% with the exception of iron. 
Accuracy and precision for the nutrients in this hypertension research study, performed 
well in all of the four databases.115  
 
To maintain validity and reliability of NDS-R, quality control measures to verify 
data entry of various food sources, are a part of the data system.92 Quality control is 
maintained by reviewing the system’s manual, and editing any improperly entered data, 
or data in error. Other quality control measures include consistency of the program 
among the nutrient values of foods that are similar and consistency of nutrient contents 
within foods. These are automatic in NDS-R. Data consistency is also maintained by 
comparing nutrient values to algorithms of expected food values.92 If discrepancies are 
found between the calculated algorithms, and database entries, nutrient ranges are flagged 
and investigated by NCC personnel. Other means of maintaining validity and reliability 
include standardization of interviewing prompts, multiple-pass approach used during 
interviewing, number of reviews of data, coding system for reference sources for nutrient 
data and inter-study comparability.116 
 
 
Physical Activity 
 
 Assessment of participant activity was accomplished using the 7 Day-Physical 
Activity Recall (7D-PAR) interview. It has been widely used since the early 1980s as a 
general measure of physical activity, either work related or non-work related, in a variety 
of studies. Participants recall activity, sleep patterns and physical activity behaviors over 
the preceding seven days during a structured face-to-face or phone interview. In addition 
to sleep, classification of activity include moderate, heavy and strenuous based on the 
instrument’s measurement criteria. Participants provide examples of activities and the 
amount of time for each activity that fit the designated categories. Metabolic equivalent 
(MET) value is assigned by the interviewer to various levels of activity based on the 
updated Compendium of Physical Activity. A MET value is calculated as the ratio of 
metabolic rate during work to the resting metabolic rate of 1.0 (4.18 kJ) kg-1·h-1. 
Multiples of the resting MET level are used to assign values to activities with a range of 
0.9 (sleeping) to 18 METs (running at 10.9 mph).37 The METs are then used to estimate 
kilocalorie expenditure.  
 
Test-retest reliability (r = 0.77, p ≤ 0.0001) was reported by Sallis and his team,117 
in a cohort of children and adolescents, while comparing interviewers completing a five 
session group training program, Gross and colleagues reported a test reliability of r = 0.99 
in healthy individuals while testing the skills of interviewers.118 Convergent validity (r = 
0.70, 0.66, p ≤ 0.05) examination was done comparing 7D-PAR with activity logs of men 
ages 34-60 years.119   
 
Still another study comparing validation of the 7D-PAR telephone interview 
version to 7D-PAR face-to-face interviews using the same protocol, reported intraclass 
correlation between the two methods for total minutes of activity for the total days as r = 
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0.96, r = 0.94 for moderate, r = 0.97 for hard, and r = 0.97 for very hard activities. In 
comparing the TriTrac-R3D accelerometer to the 7D-PAR phone interview, Pearson 
product correlation for the total physical activity for the 7 days were r = 0.43, r = 0.31 
(moderate activity), r = 0.39 (hard activity), and r = 0.78 (very hard activity). Pearson 
Product correlation coefficients for the week comparing the face to face 7D-PAR and 
TriTrac-R3D was r = 0.41, r = 0.33 (moderate activity), r = 0.43 (hard activity) and r = 
0.74 (very hard activity). These data show that the 7D-PAR phone interview and the 7D-
PAR face to face methods were similar for obtaining self-reported activity from adult 
participants. The results were also comparable to validated activity measured by the 
TriTrac-R3D.120 
 
 Criterion validity of the 7D-PAR was evaluated in a group of young adult males 
and females in the moderately overweight category using doubly labeled water (DLW). 
The parameters assessed by the DLW were compared to total daily energy expenditure 
(TDEE) and the physical activity energy expenditure (PAEE). The comparison of activity 
expenditure measured by the DTW and the 7D-PAR showed no significant difference in 
both males and females. Thus, the 7D-PAR is a practical means to estimate TDEE and 
PAEE in groups.101 
 
 
Clinical Data 
 
 Electronic and paper charts from the university hospital’s transplant clinic were 
used to gather demographic information and clinical data at baseline, 3 and 6 months and 
entered into the database for the larger longitudinal prospective study. Demographic 
information included age, gender, race/ethnicity, education level and socioeconomic 
information. Clinical data included date of transplant, number of hospitalizations 
following transplant, immunosuppressant medications, pre-transplant history and diabetes 
and hypertension and post transplant diabetes. Other data gathered included weight and 
BMI at baseline, 3 and 6 months following transplant.  
 
 
Data Analysis 
 
 Data analysis was accomplished through the use of the SPSS/PSAW version 18.0. 
The dietary data were downloaded from NDS-R into an Excel spreadsheet for data 
cleaning. Activity data were downloaded from a database used for activity data storage 
was downloaded into an Excel spreadsheet. The data were then downloaded into 
SPSS/PSAW v. 18 for analysis. Descriptive statistics will be used to describe the 
participants with frequency distributions used to describe categorical data such as age, 
gender, race and clinical data. Repeated measures ANOVAs were used to compare 
nutrient changes and physical activity changes from baseline to 3 months to 6 months. 
Pearson’s correlations were run on the dietary intake variables, physical activity variables 
and age, gender, race and immunosuppressant medications to check for relationships of 
these variables to weight gain. Data management included keeping all hard copies of data 
in a locked cabinet with only participant identification numbers. Computers storing data 
are password protected. NDS-R data is automatically saved every 24 hours in the system. 
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Research Questions 
 
 Question 1. Do transplant recipients increase their food and calorie intake 
following transplantation, and if so, how? Nutrient intake at baseline, 3 and 6 months 
were obtained through 24-hour dietary recalls and entered into NDS-R. Caloric intake 
was automatically calculated using NDS-R software for analysis. Repeated measures 
ANOVA was performed to examine the differences in nutrient intake at the three time 
points. Descriptive statistics were used to characterize the sample at the various time 
points. An a priori significance of ≤ 0.01 was used with the ANOVA to reduce the risk of 
type I error.  
    
 Question 2. Do transplant recipients increase their physical activity following 
transplant and, if so, at what time point? 7D PAR recalls were obtained at baseline, 3 and 
6 months via face to face report or telephone recalls. Repeated measures ANOVA was 
performed to examine the differences in physical activity at the three time points. 
Descriptive statistics were used to characterize  the sample at the three time points. An a 
priori significance of ≤ 0.01 was used with the ANOVA to reduce the risk of type I error.  
 
 Question 3. What is the relationship among diet, physical activity, and other 
factors (i.e., medications, race, age, gender) to weight gain in post kidney transplant 
recipients? Pearson’s correlations were run on the dietary intake variables, physical 
activity variables and age, gender, race and immunosuppressant medications to check for 
relationships in these variables to weight gain. This was done to examine if there is a 
relationship in these variables and weight gain following kidney transplantation. 
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CHAPTER 4. RESULTS AND CONCLUSIONS 
 
 
Introduction 
 
Weight gain following kidney transplantation is a significant issue. Fifty to 90% 
of renal transplant recipients gain weight after transplant,2 with an average first year 
weight gain of 22.7 to 25.0 pounds (10.3 to 11.8 kg).3,4 Data from a retrospective review 
examining weight gain and changes in body mass index (BMI) categories during the first 
year following renal transplantation in our transplant center demonstrated a significant 
increase in weight of 13.6 to 70.4 pounds (6.2 kg to32 kg).7 This is significantly more 
than the 1.8-2 pounds (approximately 0.9 kg) average yearly weight gain reported in 
adults in the United States121 and the recommended lifetime increase of < 11 pounds (5 
kg).122  
 
Undoubtedly, obesity can be attributed to environmental factors such as increased 
energy intake of kilocalories and decreased physical activity or expended energy.121 In 
much the same way, it is believed that kidney transplant recipients increase their intake of 
kilocalories due to an increase in appetite and removal from dietary restrictions imposed 
in the management of chronic renal disease prior to transplantation, but do not increase 
their physical activity appreciably following transplantation. However, there is little 
documented about the food intake and physical activity levels of kidney transplant 
recipients and the relationship of these environmental factors to weight gain. 
 
Improved allograft outcomes have resulted from advances in immunosuppressant 
therapies.62 As a result of improved appetite123 following renal transplantation, these 
individuals are at risk for weight gain leading to obesity.23 Increased risk for 
cardiovascular disorders is often attributed to obesity following kidney transplantation,30 
and presently, the leading cause of death following kidney transplantation is 
cardiovascular disease.124 Past research has targeted allograft rejection and advances in 
immunosuppressive medication regimes to preserve the newly transplanted kidney. With 
post transplant obesity and cardiovascular related issues being prevalent following 
transplant, the focus of transplant research should now focus on clinical nutrition.1 
 
The purpose of this study was to examine dietary intake and physical activity of 
kidney transplant recipients at baseline, 3 and 6 months following transplantation to 
identify factors contributing to weight gain. The following research questions were asked: 
(1) Do kidney transplant recipients increase their food and calorie intake following 
transplantation, and if so, to what extent and at what time point? (2) Do kidney transplant 
recipients increase their physical activity following transplant and, if so, to what extent 
and at what time point? (3) What is the relationship of dietary intake, physical activity, 
and other factors (i.e., age, gender, race, medications) to weight gain in kidney transplant 
recipients? 
 
An increased awareness of the factors leading to weight gain following kidney 
transplantation will facilitate the development of interventions to aid in the prevention of 
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significant weight gain. A greater understanding of the environmental factors leading to 
weight gain following kidney transplantation will assist health care professionals in the 
development of tailored dietary and physical activity protocols to lessen or ameliorate 
significant weight gain leading to obesity following kidney transplantation. 
 
 
Methods 
 
 This descriptive, correlational study included secondary data to examine dietary 
intake, physical activity and other variables (e.g., age, gender, race, immunosuppressant 
medications) associated with weight gain post-kidney transplant. After obtaining 
institutional review board approval, dietary intake, physical activity and clinical data 
were used from participants enrolled in a larger, longitudinal study exploring 
environmental and genetics factors and their association to weight gain and obesity after 
kidney transplantation. The participants in the parent study were transplanted between 
August 2007 and August 2009 at a large Mid-south university-hospital-based transplant 
institute. The inclusion criteria for the parent study included (1) 18 years of age or older 
and (2) able to read and understand English. Exclusion criteria for the parent study were 
(1) receiving steroid therapy prior to the time of transplantation and (2) death or loss of 
allograft. 
 
Forty-eight participants who had reached their 6 month time point and had 
baseline, 3 and 6 month dietary, physical activity and weight data were considered for the 
secondary data analysis. Participants were excluded if they lost greater than 10% body 
weight from baseline to 6 months. Blackburn and colleagues109 identified weight loss 
greater than 10% in a 6 month period as significant. This percent weight change, usually 
accompanies poor oral intake or medical illnesses,110 and indicates a state of protein 
malnourishment, impacting  immune functioning, morbidity and mortality.109 This study 
looked at dietary intake, physical activity and age, gender, race, and immunosuppressant 
medications and their association to weight gain, thus excluding the four participants who 
had lost greater than 10% body weight in the first 6 months following kidney 
transplantation.   
  
Four participants (1 African American male, 1 African American female, 1 
Caucasian male, 1 Caucasian female) were excluded because they had lost more than 
10% of their baseline body weight at 6 months. Thus, 44 participants (22 males and 22 
females) who had signed informed consent for the parent study and had reached their 
sixth month time point since transplantation were included in this secondary data 
analysis.  
 
 
Data Collected/Procedure 
 
 For the parent study dietary intake, physical activity, heights, weights and BMI 
were obtained from all participants at the time of transplant (baseline) and 3 and 6 
months following transplantation. Dietary intake and physical activity recalls were done 
by the same research team members who were well versed in gathering recall data. 
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Heights, weights and BMI were measured and recorded by the transplant clinic personnel 
in the electronic health record at the time of transplant and at 3 and 6 month check-ups 
following transplantation. The same calibrated medical scales were used to weigh 
participants at each time interval in the transplant clinic. Other clinical data collected 
from the database included kidney donor sources, numbers of hospitalizations in the first 
six months following transplantation, suspected rejection episodes, baseline incidence of 
hypertension and diabetes, and immunosuppressant medications. 
 
Using telephone interviews, dietary and physical activity recalls were obtained 
after the first two weeks following transplantation. This period of time was considered to 
be reflective of the return to regular eating patterns while physical activity recall to be 
representative of activity and exercise engaged in the period just prior to transplantation. 
 
Most of the recall interviews were conducted over the telephone or during 
regularly scheduled appointments in the transplant clinic. Twenty-four hour dietary 
intake was obtained at baseline and at 3 and 6 months following transplantation to 
include one weekend day and two weekdays of food and fluid. Physical activity at 
baseline and at 3 and 6 months was done by telephone recall using a 7 day recall of the 
past week’s activity along with usual activity of the past 3 months. Age, gender, race and 
immunosuppressant medications were obtained by reviewing chart information. 
 
 
Dietary Intake 
 
 This study used the Nutrition Data System for Research (NDS-R) to assess dietary 
intake at baseline, and at three and six months. Data were downloaded from the parent 
study database The NDS-R, developed by the Nutrition Coordinating Center at the 
University of Minnesota is a windows-based dietary analysis program used for entry and 
analysis of dietary intake. Considered the “gold standard” for dietary analysis, it contains 
data for 160 nutrients and food constituents, updated yearly to reflect changes in nutrient 
composition of foods and food market changes.91 
 
 To evaluate validity and reliability, quality control measures to verify data entry 
of various food sources, need to part of a data system.92 Reviewing the system’s manual, 
editing any improperly entered data or data in error, consistency of the program among 
the nutrient values of foods that are similar and consistency of nutrient contents within 
foods are automatic quality control features in NDS-R. Data consistency is also 
maintained by comparing nutrient values to algorithms of expected food values.92 If 
discrepancies are found between the calculated algorithms, and what is contained in the 
database, nutrient ranges are flagged and investigated by NCC personnel. Still another 
means of validity and reliability is demonstrated by the number of reviews of the data. 
The first review is with the participant, the second occurs when the investigator reviews 
the data following the interview and the third is by confirming amounts on any data entry 
errors. Standardization of food portions through the use of common household 
measurements such as measuring cups and rulers also increase validity and reliability of 
the data received and entered. 
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Physical Activity 
 
 This study used the 7Day-Physical Activity Report (7D-PAR) to assess physical 
activity at baseline and at three and six months following kidney transplantation. The 7D-
PAR is an instrument for gathering self-reported physical activity recall from participants 
through the use of interview, either face to face or per telephone. Based on participants’ 
response to 7D-PAR recalls, five subsets of physical activity (sleep, light, moderate, hard 
and very hard) were studied to see if physical activity changed from baseline to 3 and 6 
months and if so, when this change in physical activity was reflected following kidney 
transplantation. Kilocalories for the five subsets of activity were recorded as well as total 
METs compared from each time point. In addition, number of days of moderate activity 
was recorded. Moderate, hard or very hard exercise performed continuously for at least 
ten minutes was recorded.100 
 
 Test-retest reliability (r = 0.77, p ≤ 0.0001) was reported by Sallis and his team117 
in a cohort of children and adolescents. While comparing interviewers completing a five 
session group training program, Gross and colleagues reported a test reliability of r = 0.99 
in healthy individuals while testing the skills of interviewers.118 Convergent validity (r = 
0.70, 0.66, p ≤ 0.05) examination was done comparing 7D-PAR with activity logs of men 
ages 34-60 years.119   
  
 
Data Analysis 
  
 Dietary intake, entered into a windows-based dietary analysis program during the 
parent study was downloaded from the database. Data cleaning involved inspecting for 
outliers. Any questionable data such as excessive amounts of nutrient intake were 
verified by first checking the original document where data was recorded and comparing 
it to data entered into the nutritional database for analysis. 
 
 Physical activity data were downloaded from the storage database for the parent 
study into an Excel spreadsheet before importing into SPSS for analysis. Cleaning the 
data involved inspecting for outliers. Any questionable data such as excessive amounts of 
physical activity were verified by first checking the original 7D-PAR interview document 
where data were recorded and comparing it to data entered into the database for analysis. 
  
 Descriptive statistics and analysis of variance (ANOVA) for repeated measure 
were used to compare dietary intake and physical activity data at baseline with 3 and 6 
months. This was done to determine if differences occurred in nutrient intake and 
physical activity following transplantation and if so, when.  Pearson product moment 
correlations were used to identify relationships between dietary intake, physical activity 
and other variables (i.e. age, race, gender and immunosuppressant medications) to weight 
gain from baseline to 3 and 6 months. Statistical analyses were performed using 
Statistical Package for the Social Sciences, Predictive Analytic Software 18 for Windows 
(SPSS/PAW v.18.0). Values of p < 0.05 were considered statistically significant. 
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Results 
 
 
Characteristics of the Sample  
   
 Forty four kidney transplant recipients were included in the study. Participant 
characteristics at baseline are reflected in Table 4.1.  
 
Mean weight and mean BMI for this group stayed relatively constant from 
baseline to 3 months, with an increase in 6 months. Data in Table 4.2 demonstrate 
increase in weight, BMI and percent change in both from baseline to 6 months. Mean 
weight increased by 9.63 lbs (4.40 kg) and mean BMI showed an increase of 1.47.  
 
Table 4.3 reflects weight by gender and race. More weight was gained by African 
American males and females, which was comparable, followed by Caucasian males. 
Caucasian females gained the least amount of weight during the 6 months following 
transplantation. 
 
At the time of transplant mean creatinine and blood urea nitrogen (BUN) were 
5.96 ± 2.89 mg/dL and 36.45 ± 15.42 mg/dL, respectively. Mean hemoglobin at the time 
of transplant was 11.31 ± 1.56 gm/dL. Co-morbid conditions pre-transplant were diabetes 
mellitus (n  = 10, 21%) and hypertension (n = 44). All transplant recipients received 
immunosuppression with prednisone at the time of transplant (Table 4.4). Additional 
immunosuppression given was MMF, tacrolimus and sirolomus. One participant was 
receiving Imuran at baseline, two participants at 3 months and 4 participants at 6 months 
were receiving Imuran in addition to other immunosuppressant medications. The majority 
of participants received 20 mg daily of prednisone at baseline and were tapered to 5 mg 
daily by 3 months post transplantation (Table 4.5). 
     
Data in Table 4.6 demonstrate the incidence of suspected rejection episodes and 
the number of hospitalizations following transplantation during the first 6 months after 
transplantation (not including the initial hospitalization for transplantation). Seven 
participants (16%) experienced suspected rejection episodes of which one was confirmed 
with biopsy post transplant. Hospitalizations post transplant were varied in number and 
causes.  
 
 
Dietary Intake  
 
 There were no significant differences noted between time points for kilocalorie 
and nutrient intakes (Table 4.7). However, kilocalories for the group were about 25% 
lower than recommended. Of the macronutrients, total protein was around 25% lower 
than recommended, while total fat was about 100% more and total carbohydrate was  
about 50% more than recommended. Percent calories from fat was about 23% higher 
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Table 4.1 Participant characteristics at baseline (time of transplant) (n = 44). 
_________________________________________________________ 
Characteristic     Baseline (percent)  
Age at transplantation years (mean, SD)  49.70 ± 13.09  
   Range, years      19-70 
   Males n (percent)    22 (50%) 
Ethnicity n (percent)  
   African American     26 (59) 
   Caucasian      18 (41) 
Donor source n (percent)  
   Cadaveric      33 (73) 
   Living related donor    10 (23) 
Diabetes Mellitus     10 (21) 
Hypertension      40 (92) 
 
 
 
 
Table 4.2 Weight and body mass index (BMI) at baseline, 3 and 6 months (n = 44). 
  
Weight/BMI Baseline 
  
3 Month 
 
6 Month 
 
Percent change 
baseline to 6 mo 
Weight (lbs) 172.46 ± 
34.05 
171.21 ± 
38.63 
182.09 ± 
38.38 
6% 
Weight range 
(lbs) 
127-240 112-242. 118.8-
255.9 
 
 
BMI (kg/m2) 26.4 ± 3.8 26.79 ± 
3.92 
28.24 ±  
4.17 
5% 
BMI (kg/m2) 
range 
19.47-33.47 19.84-
34.85 
21.30-
38.98 
 
 
 
Abbreviations: BMI, Body Mass Index; M, male; F, female; lbs, pounds; kg/m2, 
kilograms per meter squared. 
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Table 4.3 Weight and BMI at baseline, and at 3 and 6 months post transplant by race and gender (n = 44). 
 
 Baseline  3 Months 6 Months       Baseline       3 Months      6 Months 
 African 
American 
African 
American 
African 
American 
    Caucasian     Caucasian     Caucasian 
 
Weights/BMI M   F M F M F M F M F M F 
Weight (lbs) 180.10 
± 27.97 
147.14 
± 18.75 
181.13 
± 35.34
145.25 
24.15 ± 
191.10 
± 33.04
158.89 
± 26.06
212.31 
± 22.70 
 
152.10 
± 20.34 
 
213.07 
± 28.25
149.21 
± 23.67
221.66 
± 31.78
155.50 
± 22.93
Weight range 
(lbs) 
133-
223 
117-
185 
140-
236 
112-
191 
152-
232 
128-
208 
155-
240 
133-
185 
146-
242 
131-
192 
148-
256 
133-
197 
 
BMI (kg/m2) 26.52 
 ± 1.65 
25.02 
 ± 3.43 
26.69 
 ± 3.45 
25.43 
 ± 4.60 
28.19 
 ± 3.0 
27.21 
 ± 5.33 
29.21 
 ± 1.98 
27.06 
 ± 2.76 
28.79 
 ± 3.62 
26.70 
 ± 3.18 
30.03 
 ± 4.07 
26.70 
 ± 3.18 
 
BMI (kg/m2) 
range 
25.14-
29.15 
19.47-
31.71 
21.92-
29.80 
19.84-
33.73 
23.80-
33.08 
21.30-
38.98 
26.72-
33.47 
24.31-
31.82 
20.99-
32.82 
24.14-
31.82 
21.25-
34.70 
24.30-
32.20 
 
∆ in lbs 
  baseline to 6  
  mo 
 
   11.1 11.7    9.3 2.4 
Percent wt  
  ∆ baseline to 
  6 mo 
   7 8    4 2 
Abbreviations: BMI, Body Mass Index; M, male; F, female; lbs, pounds; kg/m2, kilograms per meter squared; mo, month; wt, weight; 
∆, change.
48 
 
Table 4.4 Frequency of prednisone dosages at baseline, and at 3 and 6 
months posttransplant (n = 44). 
 
Dosage Baseline 3 Months 6 Months 
50 mg n = 1  n = 0 n = 0 
20 mg n = 35 (73%) n = 0 n = 0 
15 mg n = 6 n = 1 n = 1 
12 mg n = 0 n = 0 n = 1 
10 mg n = 4 n = 3 n = 1 
  5 mg n = 2 n = 42 (89%) n = 40 (85%) 
2.5 mg n = 0 n = 0 n = 2 
  0 mg n = 0 n = 1 n = 1 
Missing n = 0 n = 1 n = 2 
 
 
 
 
Table 4.5 Immunosuppression medications by time period (n = 44). 
 
Medication Baseline 3 Months 6 Months 
Prednisone n = 44 (91%) n = 44 (91%) n = 42 (95%) 
Mycophenolate n = 43 (98%) n = 40 (91%) n = 41 (93%) 
Tacrolimus n = 38 (86%) n = 44 (100%) n = 41 (93%) 
Sirolimus n = 1    (2%) n = 2   (5%) n = 4   (9%) 
Immuran n = 1    (2%) n = 2   (5%) n = 4   (9%) 
 
 
 
 
Table 4.6 Hospitalizations and suspected rejection episodes (n = 35). 
 
Hospitalization/Rejection episode From baseline to 6 months 
n (%) 
Hospitalizations 32 (73) 
Rejection episodes 7 (16) 
  Confirmed no with biopsy 6 (86) 
  Confirmed yes with biopsy 1 (14) 
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Table 4.7 Nutrient intake at baseline to 3 and 6 months posttransplant (n = 44).  
 
Nutrient Baseline 3 Months 6 Months 
Kilocalorie 1709.1 ± 566.4 1747.6 ± 608.2 1638.1 ± 531.3 
Total fat (g) 70.0 ± 23.4 75.4 ± 28.2 69.1 ± 25.7 
Total CHO (g) 202.1 ± 86.8 193.8 ± 85.2 188.9 ± 71.4 
Total protein(g) 72.2 ± 22.5 76.8 ± 24.8 69.0 ± 19.7 
Cholesterol 292.7 ± 117.3 320.0 ± 158.0 293.9 ± 161.3 
Total fiber 12.3 ± 6.1 12.9 ± 5.9 12.7 ± 5.6 
Vitamin D 3.73 ± 3.7 5.00 ± 7.1 3.26 ± 1.8 
Vitamin C 55.4 ± 38.8 50.5 ± 33.9 54.1 ± 40.7 
Calcium 566.6 ± 253.7  605.7 ± 278.9 558.5 ± 62.5 
Phosphorus 1016.3 ± 347.0 3 ± 390 971 ± 300.1 
Sodium 3134 ± 922.2 3306.6 ± 1290.8 2981.1 ± 248.1 
Potassium 2018.3 ± 976.6 1968.5 ± 749.9 1862.1 ± 82.3 
% Calories fat 36.8 ± 6.7 36.8 ± 6.7 37.1 ± 5.6 
% Calories CHO 45.9 ± 8.2 43.6 ± 8.3  45.0 ± 7.15 
% Calories prot 17.7 ± 4.0 18.5 ± 5.1  17.9 ± 4.4 
Omega-3 FAs 1.5 ± .7 1.8 ± 1.1 1.3 ± .6         
Abbreviations: CHO, carbohydrate; prot, protein; cal, calories; FAs, fatty acids; g, gram; 
mcg, microgram; mg, milligram. 
Note: No significant differences were found in time points. 
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while percent calories from carbohydrate was around 10% less than suggested. 
Cholesterol intake was in line with recommended intake, while fiber was about 50% less 
than recommended.  
 
 Of the micronutrients, vitamins D and C, calcium, phosphorus and potassium 
were roughly 50% lower than suggested values, while sodium was around 36% higher 
than what is recommended. Omega-3 fatty acid intake was in line with recommended 
intake values. Table 4.8 shows the percent of participants at or above the DRI for each 
nutrient variable at baseline, 3 and 6 months. 
 
Table 4.9 demonstrates significance by race and gender, showed kilocalorie intake 
higher in males of both races than females at all time points (p ≤ 0.05). AA males and 
females had higher kilocalorie intakes than Caucasians at baseline and 3 months and 
fairly comparable intakes at 6 months.  
  
Total fat intake was higher in males from baseline to 3 months (p ≤ 0.035). AA 
males and Caucasian males had the highest mean intake of fat and are fairly comparable 
between the two groups of male participants. AA females have a higher fat intake 
compared to Caucasian females. Means for total fat intake were higher in AAs than in 
Caucasians. 
 
Total carbohydrate intake showed higher intakes in males from baseline to 3 
months (p ≤ 0.048). Carbohydrate intake was higher in males of both races compared to 
females of both races. Mean carbohydrate intake was higher in Caucasian males than AA 
males and higher in AA females than in Caucasian females. 
 
No statistical significance was demonstrated in total protein intake according to 
race and gender. Higher mean protein intakes were seen at all time points in AA males 
compared to Caucasian males and higher in AA females than in Caucasian females. 
Higher mean total intake of protein was seen in AA males at all time points. 
 
 Cholesterol intake was higher from baseline to 3 months and according to race (p 
≤ 0.012) and gender (p ≤ 0.004). Higher mean intake for cholesterol was seen in AA 
males compared to Caucasian males and AA and Caucasian females. According to race 
and gender, AA males and females have higher mean cholesterol intakes than Caucasian 
females. 
 
 Total fiber intake was higher according to race (p ≤ 0.035) and significance 
according to gender (p ≤ 0.067). Mean for total fiber intake was higher in Caucasian race 
than in AA race. Mean total fiber intake was higher in Caucasian males than in Caucasian 
females and higher in AA males compared to AA females. 
 
 Micronutrient intake of vitamin D and vitamin C were not statistically significant. 
However, calcium intake showed for race (p ≤ 0.045), gender (p ≤ 0.003) and race and 
gender (p ≤ 0.015). Caucasians had higher mean intake of calcium at all time points 
compared to AA participants. Males (both races) had higher mean intake of calcium than  
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Table 4.8 Percent at or above Daily Recommended Intake for nutrients (n = 44). 
 
Nutrient                           Time point Daily recommended intake 
(DRI) 
Percent at or above DRI 
Kilocalorie Baseline 30 kcal/kg weight 9 
 3 months 28 kcal/kg weight 7 
 6 months 28 kcal/kg weight 4 
Total fat Baseline 35 grams 98 
 3 months 35 grams 93 
 6 months 35 grams 91 
Total CHO Baseline 130 grams 82 
 3 months 130 grams 73 
 6 months 130 grams 86 
Total protein Baseline 1.2 grams/kg weight 23 
 3 months 0.8 grams/kg weight 70 
 6 months 0.8 grams/kg weight 57 
Cholesterol Baseline < 130 grams 91 
 3 months < 130 grams 91 
 6 months < 130 grams 84 
Total fiber Baseline 25-30 grams 5 
 3 months 25-30 grams 5 
 6 months 25-30 grams 5 
Vitamin D Baseline 10 micrograms 7 
 3 months 10 micrograms 9 
 6 months 10 micrograms 0 
Vitamin C Baseline 70 milligrams 36 
 3 months 70 milligrams 23 
 6 months 70 milligrams 23 
Calcium Baseline 800-1000 milligrams 18 
 3 months 800-1000 milligrams 18 
 6 months 800-1000 milligrams 14 
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Table 4.8 (continued). 
 
Nutrient Time point Daily recommended intake 
(DRI) 
Percent at or above DRI 
Phosphorus Baseline 1200-1500 milligrams 23 
 3 months 1200-1500 milligrams 25 
 6 months 1200-1500 milligrams 20 
Sodium Baseline 1000-3000 milligrams 100 
 3 months 1000-3000 milligrams 100 
 6 months 1000-3000 milligrams 100 
Potassium Baseline 1000-3000 milligrams 93 
 3 months 1000-3000 milligrams 89 
 6 months 1000-3000 milligrams 89 
Percent calories fat Baseline 30 % 84 
 3 months 30 % 93 
 6 months 30 % 86 
Percent calories CHO Baseline 50% 43 
 3 months 50% 20 
 6 months 50% 18 
Percent calories 
protein 
Baseline 20% 16 
 3 months 20% 23 
 6 months 20% 32 
Omega-3 fatty acids Baseline 1.10 milligrams 75 
 3 months 1.10 milligrams 66 
 6 months 1.10 milligrams 57 
Abbreviations: kcal, kilocalorie; CHO, carbohydrate; kg, kilogram 
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Table 4.9 Nutrient intake by race and gender at baseline, 3 and 6 months and total (n = 44). 
 
             African American                  Caucasian 
Nutrient/ 
Threshold 
Time  
point 
Male  
(n = 11) 
Female  
(n = 15) 
Male  
(n = 11) 
Female  
(n = 7) 
Kilocalorie 
  30 kcal/kg wt. bl  
  28 kcal/kg wt. (3 & 6  
  mo) 
Bl 
3 mo 
6 mo 
 
1652.3 ± 296.2 
1928.1 ± 288.6 
1802.4 ± 288.6* 
1849.9 ± 754.2 
1668.9 ± 643.7 
1442.0 ± 662.8 
 
1753.9 ± 621.0 
1883.3 ± 667.4 
1882.2 ± 524.6* 
 
1426.4 ± 174.5 
1419.6 ± 482.6 
1416.5 ± 4 
 
Total fat (g) 
  35 g 
Bl 
3 mo 
6 mo 
 
71.4 ± 29.1 
83.3 ± 24.0* 
79.0 ± 19.7 
72.9 ± 27.5 
75.2 ± 30.3 
60.1 ± 26.0 
 
71.1 ± 29.1 
78.6 ± 28.3* 
78.8 ± 28.5 
 
60.1 ± 10.1 
58.8 ± 28.5 
57.6 ± 26.0 
 
Total carbohydrate 
(g) 
  130 g 
Bl 
3 mo 
6 mo 
 
176.9 ± 40.1 
216.7 ± 85.6* 
199.2 ± 44.0 
225.6 ± 115.6 
173.2 ± 86.9 
166.3 ± 92.1 
 
220.9 ± 91.4 
221.3 ± 95.9* 
223.0 ± 68.0 
 
161.8 ± 35.0 
158.6 ± 45.2 
168.0 ± 40.4 
 
Total protein(g) 
  1.2g/kg wt. bl 
  0.8g/kg wt. (3 & 6  
  mo) 
Bl 
3 mo 
6 mo 
 
77.4 ± 24.9 
81.4 ± 22.1 
76.9 ± 10.5 
76.9 ± 24.4 
76.9 ± 23.5 
61.1 ± 21.0 
 
66.1 ± 22.4 
77.2 ± 23.5 
76.6 ± 22.7 
 
63.6 ± 9.5 
68.8 ± 34.4 
61.8 ± 17.1 
 
Cholesterol  
  < 130 g 
Bl 
3 mo 
6 mo 
 
324.4 ± 36.0 
368.7 ± 168.0* 
337.8 ± 201.2 
294.0 ± 45.2 
330.6 ± 144.6* 
330.4 ± 201.2 
 
282.3 ± 36.0 
292.3 ± 124.7* 
248.6 ± 117.1 
 
256.4 ± 45.2 
264.2 ± 217.2 
217.9 ± 135.8 
 
Total fiber 
  25-30g 
Bl 
3 mo 
6 mo 
 
11.2 ± 3.5 
12.4 ± 4.4 
13.7 ± 5.0 
11.8 ± 7.0 
10.1 ± 6.0 
9.4 ± 5.3 
 
15.1 ± 7.8 
15.7 ± 5.0 
16.0 ± 4.7 
 
10.7 ± 5.0 
15.1 ± 7.0 
12.6 ± 6.0 
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Table 4.9 (continued). 
 
          African American                 Caucasian 
Nutrient/ 
Threshold 
  Time  
point 
Male  
(n = 11) 
Female  
(n = 15) 
Male  
(n = 11) 
Female  
(n = 7) 
Vitamin D (mcg) 
  10 mcg 
Bl 
3 mo 
6 mo 
4.2 ± 1.9 
4.2 ± 1.9 
4.1 ± 1.7 
 
2.8 ± 1.4 
7.3 ± 10.5 
2.7 ± 1.6 
 
2.8 ± 1.3 
4.2 ± 1.9 
3.7 ± 1.9 
 
2.6 ± 1.6 
5.0 ± 8.4 
2.4 ± 1.6 
 
Vitamin C (mg) 
  70 mg 
Bl 
3 mo 
6 mo 
 
45.9 ± 24.2 
54.1 ± 39.7 
56.0 ± 49.2 
 
52.3 ± 41.5 
51.6 ± 37.0 
45.2 ± 34.2 
 
54.1 ± 42.4 
47.8 ± 31.2 
63.5 ± 41.6 
 
78.8 ± 44.0 
46.6 ± 27.0 
55.5 ± 40.1 
 
Calcium (mg) 
  800-1000mg 
Bl 
3 mo 
6 mo 
 
546.1 ± 193.2 
568.4 ± 199.3 
486.1 ± 99.7 
 
536.4 ± 269.6 
515.7 ± 272.0 
843.3 ± 327.7 
 
702.7 ± 315.0 
836.8 ± 316.3 
843.3 ± 327.7 
 
449.9 ± .9 
494.3 ± 128.9 
470.6 ± 129.4 
 
Phosphorus (mg) 
  1200-1500mg 
Bl 
3 mo 
6 mo 
 
1041.6 ± 755.7 
1019.5 ± 294.5 
3.5 ± 232.6 
 
2.0 ± 414.7 
1027.8 ± 421.9 
834.6 ± 277.6 
 
1029.9 ± 419.6 
1198.6 ± 404.5 
1173.1 ± 315.0 
 
878.3 ± 179.2 
930.9 ± 1655.2 
815.7 ± 219.9 
 
Sodium (mg) 
  1000-3000 mg  
Bl 
3 mo 
6 mo 
 
3157.54 ± 801.9 
3521.2 ± 1157.7 
3254.2 ± 482.3* 
3241.0 ± 1043.3 
3109.4 ± 1276.2 
2553.5 ± 1.8 
 
3131.3 ± 910.43 
3663.0 ± 1222.3 
3652.0 ± 1817.7 
 
2871.6 ± 996.5 
2831.8 ± 1655.2 
2414.22 ± 945.2 
 
Potassium (mg) 
  1000-3000 mg 
Bl 
3 mo 
6 mo 
 
1817.6 ± 971.5 
1727.1 ± 490.0 
1955.2 ± 673.0 
 
1928.8 ± 971.5 
1899.9 ± 641.0 
1581.9 ± 647.2 
 
2386.6 ± 1326.2 
2201.2 ± 659.1 
2260.5 ± 581.67 
 
1947.1 ± 829.9 
2128.6 ± 1303.6 
1690.0 ± 708.8 
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Table 4.9 (continued). 
 
              African American                    Caucasian 
Nutrient/ 
Threshold 
  Time  
 point 
   Male  
   (n = 11) 
    Female  
   (n = 15) 
    Male    
    (n = 11) 
    Female  
    (n = 7) 
Percent calories fat 
30% 
Bl 
3 mo 
6 mo 
 
38.2 ± 6.4 
37.9 ± 4.7 
39.0 ± 6.0 
 
36.4 ± 6.3 
39.3 ± .3 
37.1 ± 4.3 
 
36.2 ± 9.0 
37.3 ± 4.6 
36.0 ± 7.4 
 
36.4 ± 4.7 
35.5 ± 5.9 
35.5 ± 4.2      
Percent calories CHO  BL 42.6 ± 8.2 46.4 ± 7.8 48.6 ± 9.3 45.8 ± 7.3  
50% 
 
 
Percent calories 
protein 
20% 
3 mo 
6mo 
 
Bl 
3 mo 
6 mo 
 
43.9 ± 8.2 
43.5 ± 5.1  
 
19.2 ± 4.7 
18.1 ± 4.8 
17.45 ± 2.5 
 
41.2 ± 10.0 
43.5 ± 6.2 
 
18.0 ± 4.2 
19.4 ± 5.7 
19.4 ± 5.9 
 
46.0 ± 5.7 
47.5 ± 8.5 
 
15.5 ± 2.6 
16.9 ± 2.4 
16.5 ± 3.2 
 
44.6 ± 8.1 
47.0 ± 7.8 
 
18.0 ± 3.4 
20.0 ± 7.5 
17.6 ± 4.4 
 
Omega-3 fatty acids 
(mg) 
1.10 mg 
Bl 
3 mo 
6 mo 
1.2 ± 0.5 
1.5 ± 0.4 
1.4 ± 0.4 
1.7 ± 0.9 
2.1 ± 0.8* 
1.1 ± 0.6 
1.5 ± 0.7 
1.7 ± .8 
1.6 ± .7 
1.7 ± 0.6 
1.9 ± 2.0* 
1.1 ± 0.3 
*p < 0.005 between groups with like symbols. 
Abbreviations: kcal/kg wt, kilocalories per kilogram body weight; mo, month; g, grams; Bl, baseline; mcg, micrograms; mg, 
milograms; CHO, carbohydrate. 
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females (both races) at all time points. Caucasian males had higher mean intakes of 
calcium at all time points than Caucasian females and AA males had higher mean intake 
of calcium than AA females at all time points. Mean phosphorus intake was higher in 
males than females (p ≤ 0.037). Mean sodium intake showed higher intakes in males of 
sodium than females (p ≤ 0.034). Similarly, mean intake of potassium was higher in 
males than in females (p ≤ 0.029). 
 
 Percent calories from fat, carbohydrates and protein did not show statistical 
significance. However, Omega-3 fatty acid intake was higher from 3 month to 6 months 
(p ≤ 0.010) in gender (p ≤ 0.018). Mean intake of omega 3 fatty acid was higher in 
females than males from baseline to 3 months. 
 
 
Physical Activity 
 
 A significant decrease was seen in mean hours of sleep from baseline to 6 month 
in pairwise comparisons (p ≤ 0.02). Other physical activity variables did not show 
significance for the total group (Table 4.10). 
 
Table 4.11 demonstrates physical activity by race and gender. Hours per day of 
light activity did not show significance. However, moderate activity was significant 
related to gender from 3 months to 6 months (p ≤ 0.046). Mean hours per day of 
moderate activity decreased in males from 3 months to 6 months, whereas moderate 
activity for females increased from 3 months to 6 months. 
 
 Hours per day of hard activity was significant from 3 months to 6 months (p ≤ 
0.04) according to race and gender. Mean increases from 3 months to 6 months were seen 
in Caucasian females. Hours per day of very hard activity was not reported by any 
participants. 
 
 Kilocalories for sleep were not significant. Kilocalories for light activity showed 
increased kilocalories for light activity in males from 3 months to 6 months (p ≤ 0.028). 
Mean increases were seen in males from 3 months to 6 months. Females stayed 
comparable at all time points. Kilocalories for moderate and hard activity were not 
statistically significant. 
 
 Total METs did not show statistical significance. Similarly the number of days of 
moderate activity reported in a 7 day period did not show statistical significance. 
 
 
Relationship between Dietary Intake and Weight Gain 
 
 Pearson’s product correlation showed no statistical association between weight 
gain at 6 months and kilocalories and macro and micronutrient intake at baseline to 3 and 
6 months except for 6 month vitamin D (p ≤ 0.003) (Tables 4.12─4.14).  
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Table 4.10 Physical activity from baseline to 6 months (n = 44). 
 
Activity variable Baseline 3 Months 6 Months 
Hours/day sleep 8.3  2.0* 7.9 ± 1.6 7.4 ± 1.9* 
Hours/day light 15.4 ± 2.4 15.5 ± 1.8 15.6 ± 2.7 
Hours/day moderate 0.4 ± 0.9 0.5 ± 0.8 0.4 ± 0.9 
Hours/day hard 0.04 ± 0.26 0.02 ± 0.1 0.07 ± 0.38 
Hours/day very hard 0 0 0 
Kilocalories/sleep 8.3 ± 2.0 7.9 ± 1.6 7.4 ± 1.9 
Kilocalories/light 23.1 ± 3.7 23.3 ± 2.7 24.0 ± 2.7 
Kilocalories moderate 1.2 ± 2.6 1.7 ± 2.7 1.3 ± 2.7 
Kilocalories hard 0 0 0 
Kilocalories very hard 0 0 0 
Number of days 
moderate activity† 
1.9 ± 2.0 2.3 ± 2.5 2.1 ± 2.2 
 
Total METs 32.7 ± 2.2 32.7 ± 2.4 33.3 ± 7.2 
*Mean difference is significant at the .05 level when adjusted for multiple comparisons  
  using Bonferroni between time points with like symbols.  
†Number of days of at least 30 minutes of moderate or harder physical activity per week.
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Table 4.11 Physical activity at baseline, 3 and 6 months according to race and gender (n = 44). 
 
Variable    Baseline    3 Months  6 Months   Baseline      3 Months    6 Months 
act    African 
  American 
  African 
American 
  African 
American 
Caucasian   Caucasian   Caucasian 
 M   F M F M F M  F M F M   F 
Hrs/ day 
sleep 
 
8 ± 2 8 ± 2 8 ± 1 8 ± 2 7 ± .9 7 ± 2 8 ± 2 9 ± 2 7 ± 1 8 ± 3 8 ± .8 8 ± 3 
Hrs/ 
day light 
 
16 ± 3 15 ± 2 16 ± 2 15 ± 3 16 ± 1 16 ± 3 15 ± 
1 
16 ± 
4 
16 ± 2 15 ± 3 15 ± 3 15 ± 4 
Hrs/ 
day mod 
 
.5 ± .9 .1 ± .2 .8 ± 
1** 
.3 ± 
.3* 
.4 ± 
.3** 
.3 ± 
.5* 
.8 ± 1 .2 ± 
.3 
.6 ± 
.5** 
.7 ±  
1.* 
.2 ± 
.2** 
1 ±  
2* 
Hrs/ 
day hard 
 
.02 ± .04 .12 ± .44 0 0 .05 ± 
.12 
0 0 0 .07 ± 
.21 
.03 ± 
.08† 
0 .40 ± 
.93† 
Hrs/ 
day  
very hard 
 
0 0 0 0 0 0 0 0 0 0 0 0 
Kcal 
sleep 
 
8 ± 2 8 ± 2 8 ± 1 8 ± 2 7 ± .9 7 ± 2 8 ± 2 9 ± 2 7 ± 1 8 ± 3 8 ± .8 8 ± 3 
Kcal light 
 
24 ± 4 23 ± 3 23 ± 2 24 ± 3 25 ± 1 24 ± 2 22 ± 2 24 ± 6 23 ± 3 23 ± 4 24 ± 1 22 ± 6 
Kcal mod 
 
2 ± 3 .40 ± .58 2 ± 4 1 ± 1 1 ± 1 1 ± 1 2 ± 4 .5 ± .9 2 ± 2 2 ± 3 .6 ± .6 4  ± 6 
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Table 4.11  (continued). 
 
Variable     Baseline   3 Months   6 Months   Baseline  3 Months   6 Months
act    African 
  American 
  African 
American 
  African 
American 
Caucasian Caucasian  Caucasian 
 M   F M  F M F M  F M F M F 
Kcal hard 
 
0 0 0 0 0 0 0 0 0 0 0 0 
Kcal very hard 
 
0 0 0 0 0 0 0 0 0 0 0 0 
Days mod 
 
2 ± 1 2 ± 2 3 ± 2 2 ± 3 3 ± 2 2 ± 2 2 ± 2 2 ± 3 2 ± 1 3 ± 3 2 ± 2 3 ± 3 
Total METs 32 ± 1 33 ± 2 33 ± 1 32 ± 3 33 ± .9 31 ± 8 33 ± 3 32 ± 2 33 ± 2 33 ± 3 35 ± 10 36±6 
* Hours/day moderate activity significant in females. 
**Hours/day moderate activity significant in males. 
† Hours/day hard activity significant in Caucasian females. 
Abbreviations: ACT, activity; AA, African American; M, male; F, female; lbs, pounds; kg/m2, kilograms per meter squared; 
mo, month; Kcal, kilocalorie; Hrs/day, hours per day; mod, moderate; MET,metabolic equivalent. 
Note: Mean difference is significant at the .05 level when adjusted for multiple comparisons using Bonferroni between 
timepoints with like symbols. 
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Table 4.12 Correlations between baseline dietary intake and weight gain at 6 
months (n = 44). 
 
Nutrient Pearson 
correlation
P-value  
(2-tailed) 
Kilocalorie 0.134 0.387 
Total fat (g) 0.073 0.635 
Total CHO (g) 0.149 0.334 
Total protein (g) 0.151 0.328 
Cholesterol 0.016 0.919 
Total fiber 0.096 0.536 
Vitamin D -0.184 0.231 
Vitamin C 0.034 0.827 
Calcium -0.001 0.996 
Phosphorus 0.099 0.521 
Sodium 0.174 0.324 
Potassium 0.147 0.446 
Percent calories fat -0.124 0.422 
Percent calories carbohydrate 0.077 0.619 
Percent calories protein 0.044 0.777 
Omega-3 fatty acids -0.139 0.367 
Note: None of the correlation coefficients is statistically significant at the 0.05 or 0.01 
level for the 18 tests shown above. 
 
 
61 
 
Table 4.13 Correlations between 3 month dietary intake and weight gain at 6 
months (n = 44). 
 
Nutrient Pearson 
correlation 
P-value  
(2-tailed) 
Kilocalorie 0.129 0.404 
Total fat (g) 0.092 0.550 
Total CHO (g) 0.138 0.371 
Total protein (g) 0.099 0.522 
Cholesterol 0.017 0.914 
Total fiber 0.099 0.524 
Vitamin D .057 0.444 
Vitamin C 0.201 0.191 
Calcium 0.089 0.567 
Phosphorus 0.070 0.653 
Sodium 0.060 0.698 
Potassium 0.058 0.706 
Percent calories fat -0.054 0.728 
Percent calories carbohydrate 0.077 0.619 
Percent calories protein 0.035 0.823 
Omega-3 fatty acids 0.047 0.763 
Note: None of the correlation coefficients is statistically significant at the 0.05 or 0.01 
level for the 18 tests shown above. 
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Table 4.14 Correlations between 6 month dietary intake and weight gain at 6 
months (n = 44). 
 
Nutrient Pearson  
correlation 
P-value  
(2-tailed) 
Kilocalorie 0.142 0.357 
Total fat (g) 0.065 0.673 
Total CHO (g) 0.148 0.338 
Total protein (g) 0.217 0.156 
Cholesterol 0.200 0.193 
Total fiber -0.011 0.944 
Vitamin D 0.444 0.003* 
Vitamin C 0.014 0.926 
Calcium 0.166 0.282 
Phosphorus 0.249 0.103 
Sodium 0.026 0.865 
Potassium 0.109 0.480 
Percent calories fat -0.165 0.285 
Percent calories carbohydrate 0.102 0.510 
Percent calories protein 0.050 0.749 
Omega-3 fatty acids 0.080 0.606 
*Correlation is significant at the 0.05 level (2-tailed). 
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Relationship between Physical Activity and Weight Gain 
 
 Data from Pearson’s product correlation showed no statistical association in the 
physical activity variables and weight gain. However, African American race and gender 
were significantly associated with 6 month weight. Caucasian race showed a negative 
correlation with 6 month weight (r = 0.300, p ≤ 0.048). Female gender was also 
negatively correlated with 6 month weight (r = 0.633, p ≤ 0.000). 
 
 
Relationship among Age, Gender, Race and Medications and Weight Gain 
 
 Data from Pearson’s product correlation showed no correlation among age, 
gender, race and medications (Table 4.15) to weight gain. However, Spearman’s rho 
showed correlation of 6 month MMF (p ≤ 0.041) and baseline tactrolimus (p ≤ 0.014) to 
weight gain. Percent weight change was significantly associated with 3 month BMI (p ≤ 
0.001) and 6 month BMI (p ≤ 0.003). 
 
 
Discussion 
 
 Weight gain after kidney transplantation has been well documented and is a risk 
factor for obesity and other co-morbid disorders. Previous studies2,3,7 have shown a 
significant amount of weight gained in the first months to years after kidney 
transplantation. Weight gain leading to obesity in some participants make them 
vulnerable for cardiac disorders,6 the number one cause of death in this population.31  
 
 In this study, kilocalorie intake was less than recommended in the total group at 
baseline, and at 3 and 6 months post-transplant. Total protein, although lower than 
suggested intake, was close to the recommended level at 6 months. Dietary intake was 
characterized by an increased total fat and total carbohydrate intake by the sample at the 
three time points but with less fiber than is recommended. This higher total fat and total 
carbohydrate intake is similar to findings in a study examining dietary intake in kidney 
transplant recipient three years after transplantation.125 In contrast to our study, these 
researchers found that kilocalorie and protein intakes for their participants were generally 
adequate. Furthermore, these researchers were gathering dietary intake data 3 years 
following kidney transplant as opposed to during the first 6 months after transplantation 
as in our study. 
 
Although similar in age (49.0 ± 12.8 years) and gender (44% female) to the 
participants in my study, those kidney transplant recipients that Heaf and colleagues125 
used to gathered dietary intake came from Denmark, as opposed to the southern region of 
the United States. Comparison of study participants related to socioeconomic status and 
access to nutritious foods was not possible.  
  
However, just in Heaf and colleagues’ findings,125 higher intake of fat in males 
was similar to fat intake in males in our study. These are clinically significant findings  
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Table 4.15 Correlations of medications with weight gain in pounds (n = 44). 
 
Medication time point Pearson 
correlation 
P-value  
(2-tailed) 
Baseline prednisone -0.164 0.287 
Three month prednisone -0.094 0.548 
Six month prednisone -0.144 0.363 
Baseline tacrolimus 0.039 0.801 
Three month tacrolimus 0.070 0.662 
Six month tacrolimus 0.039 0.639 
Baseline MMF 0.144 0.358 
Three month MMF 0.050 0.766 
Six month MMF -0.045 0.778 
Abbreviations: MMF, mycophenolate mofetil. 
Note: None of the correlation coefficients is statistically significant at the 0.05 or 0.01 
level for the 9 tests shown above. 
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that could place these transplant recipients at risk for accelerated atherosclerosis and 
cardiovascular morbidity as seen in other studies. 
 
Similarly, researchers in Mexico report significantly higher ingestion of proteins 
and fats than recommended DRIs (p ≤ 0.05) in kidney transplant recipients in eight states 
in Mexico. The highest fat intakes were in those states bordering the United States. It was 
thought that these findings reflected similar eating habits as the population in the United 
States. As would be expected, BMIs were higher in those transplant recipients with the 
higher intakes of proteins and fats compared to those with less dietary intake of these 
macronutrients.17  
  
 Sodium intake was higher than the recommendations at all time points which 
could contribute to post transplant hypertension. Since 92% of the participants in this 
study were hypertensive at baseline, sodium intake should be at a more conservative 
intake of 1 to 3 grams given that hypertension was still present post-transplant.16 At the 
same time, these individuals could be at risk for hypertension due to the impaired sodium 
excretion effects of calcineurin inhibitors although less hypertensive effects are seen with 
tacrolimus.107 Potassium intake was lower than recommended in our study and similar to 
others.125 since potassium requirements are varied following transplantation. Lower 
potassium intakes in our participants could be attributed lower intakes of fruits and 
vegetables containing potassium. Another contributor to a lower potassium intake is 
recommendations by the transplant nephrologists for lower intake of potassium-rich 
foods since some of the immunosuppressant medications can contribute to hyperkalemia. 
 
 Also similar to findings of other researchers, participants in the current study 
consumed lower amounts of vitamin D125 and calcium126 which could be contributing 
factors to the development of  osteoporosis and stress fractures. Similar to kidney 
transplant recipients in Denmark127 and Ireland,126 findings suggest, as in our study, that 
calcium and vitamin D intakes are inadequate following kidney transplantation in these 
samples. In a larger sample with a mean age of 53.6 ± 11.8 years, Ewers and 
colleagues127 found that 81% of their sample was deficient in vitamin D and calcium. 
 
 Not only are these kidney transplant recipients prone to the development of 
osteoporosis and stress fractures due to the inadequate intake of vitamin D and calcium, 
increased weight gain could be a contributing factor to these conditions following kidney 
transplantation. Kamycheva and colleagues128 in Norway found a significant association 
between calcium intake and BMI in males and an association between vitamin D intake 
and BMI in both genders. However, further studies need to be done to determine if there 
is an association between weight gain and vitamin D deficiency.  
 
Similar to our study, these researchers noted a low intake of dairy products in 
their participants’ dietary recalls, thus offering an explanation for the lower amounts of 
intake of vitamin D and calcium. One difference in food in Norway and the United 
States, is the lack of fortified foods with vitamin D in Norway, possibly explaining one 
reason for the lowered intake in that study sample.  
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 Physical activity results suggest that for the most part, participants did not show 
significant variation over time in the physical activity subsets of sleep, light, moderate, 
hard and very hard activity. Similar to Nielens and colleagues20who studied activity 
levels in renal transplant recipients before transplant and at 1 year following 
transplantation, our findings indicate that the majority of the participants increased light 
activity post transplantation. Another similarity in our study and Nielens20was that hours 
per day for sleep decreased in their participants from baseline to one year, whereas 
participants in my study decreased the number of hours of sleep from baseline to 6 
months. These findings suggest that some of the hours spent sleeping at baseline (perhaps 
related to their health status due to uremia prior to transplantation), are now being spent 
in light physical activities. 
 
 Unlike the study by Nielens,20 my study did show that kilocalories for light 
activity indicated mean increased only in males from 3 to 6 months, with females 
remaining comparable at all time points. Also kilocalories for moderate and hard activity 
were not significantly different from each time point.  
 
 Although no significant relationships were demonstrated among dietary intake, 
physical activity and age, gender, race and immunosuppressant medications, clinical 
significance exists when reviewing the high amounts of total fat and carbohydrates at all 
time points. These higher macronutrient intakes, coupled with low levels of physical 
activity, could put these participants at risk for weight gain. It is also important to note 
that this group of participants also had low intakes of total fiber that could contribute to 
weight gain. Low levels of micronutrients (i.e., calcium, vitamin D) could put them at 
risk for bone deterioration following transplantation.  
 
Similar to other studies, weight gain has been demonstrated in individuals who 
may have a genetic predisposition to weight gain related to ethnicity.4,7,129 Although in 
our study African American males and females tended to gain more weight in the first 6 
months after kidney transplant, a significant difference was not demonstrated as in other 
studies.  Since African American participants gained more weight in this study than 
Caucasian males and females, these two groups could be more at risk for weight gain 
following kidney transplantation. Along with being at risk for obesity, this group of 
transplant recipients may also develop undesirable conditions such as CAD, 
hypertension, hyperlidemia and new onset diabetes mellitus.2,1,62 
 
 
Limitations 
 
 Since the dietary intake and physical activity data are self-reported, there are 
some limiting factors associated with this type of data collection. Memory of the 
preceding 24 hour period for the dietary intake recall and the 7 days preceding the 
physical activity recall could be seen as limitations of this study.  
 
Also, dietary baseline data, obtained approximately 2 weeks following kidney 
transplantation, could be different than data obtained in the weeks or months preceding 
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transplantation. Baseline physical activity data, also collected about 2 weeks following 
transplantation, reflects the participants’ recall of their physical activity just prior to 
kidney transplantation.  
 
Baseline steroid dosages were higher than at 3 and 6 months which could increase 
appetite during the first weeks following transplantation. Thus, steroid use during the 
early period following transplantation could have affected an increase in dietary intake.  
 
 A factor that may affect the generalizability of this study to a larger kidney 
transplant population is the small sample size. Furthermore, the study participants were 
not randomly selected but were all consented in a larger parent study from the same 
transplant center in the mid-south area representing participants from Tennessee, 
Arkansas and Mississippi, predominately.   
 
 
Conclusions 
 
 Kidney transplant recipients are at risk for weight gain from a number of factors. 
However, little consideration has been given to what kidney transplant recipients are 
eating and the effect dietary intake has on weight gain in this population. High intakes of 
total fat and carbohydrates, along with low intake of fiber put these kidney transplant 
recipients at risk for co-morbid disorders as well. Physical activity data from this study 
suggest that kidney transplant recipients are not changing their physical activity levels 
significantly by 6 months following transplantation compared to their baseline activity 
levels. 
 
The implications of these findings are that dietary assessments, including 24 hour 
dietary intake, and physical activity assessments should continue to be monitored for at 
least one year or longer following transplantation, to examine effects of dietary intake 
and physical activity on weight gain. Dietary and physical activity data from this study 
suggest the need for interventions to teach individuals who have undergone kidney 
transplantation, dietary and physical activity factors that could prevent weight gain in the 
post transplant period. Nurses, in collaboration with transplant dietitians and other 
members of the transplant team, can be instrumental in designing interventions that will 
accomplish short term goals of weight management, while employing gradual dietary 
changes in the levels of fat, carbohydrates and fiber that are more in line with 
recommended values. Along with these dietary intake changes, physical activity tailored 
to each transplant recipient could be developed and encouraged with follow-up during the 
intervention period. 
 
 
68 
 
LIST OF REFERENCES 
 
 
1. Ward HJ. Nutritional and metabolic issues in solid organ transplantation: targets for 
future research. J Ren Nutr. Jan 2009;19(1):111-122. 
 
2. Baum CL. Weight gain and cardiovascular risk after organ transplantation. JPEN. 
2001;25:114-119. 
 
3. Clunk JM, Lin CY, Curtis JJ. Variables affecting weight gain in renal transplant 
recipients. Am J Kidney Dis. Aug 2001;38(2):349-353. 
 
4. Patel MG. The effect of dietary intervention on weight gains after renal transplantation. J 
Ren Nutr. Jul 1998;8(3):137-141. 
 
5. Moore LW, Gaber AO. Patterns of early weight change after renal transplantation. J Ren 
Nutr. 1996;6(1):21-25. 
 
6. Johnson C, Gallagher-Lepak S, Zhu YR, et al. Factors influencing weight gain after renal 
transplantation. Transplantation. 1993;56(4):822-827. 
 
7. Cashion AK, Sanchez ZV, Cowan PA, Hathaway DK, Costello AL, Gaber AO. Changes 
in weight during the first year after kidney transplantation. Prog In Transplant. 
2007;17(1):40-47. 
 
8. Holley JL, Shapiro R, Lopatin WB, Tzakis AG, Hakala TR, Starzl TE. Obesity as a risk 
factor following cadaveric renal transplantation. Transplantation. Feb 1990;49(2):387-
389. 
 
9. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B. 
The effect of body mass index on long-term renal allograft survival. Transplantation. 
Nov 1999;68(9):1294-1297. 
 
10. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal 
transplant outcomes: a significant independent risk factor for graft failure and patient 
death. Transplantation. Jan 2002;73(1):70-74. 
 
11. Feldman HI, Fazio I, Roth D, et al. Recipient body size and cadaveric renal allograft 
survival. J Am Soc Nephrol. Jan 1996;7(1):151-157. 
 
12. Modlin CS, Flechner SM, Goormastic M, et al. Should obese patients lose weight before 
receiving a kidney transplant? Transplantation. Aug 1997;64(4):599-604. 
 
13. Lindqvist R, Carlsson M, Sjoden PO. Coping strategies of people with kidney transplants. 
J Adv Nurs. Jan 2004;45(1):47-52. 
 
14. Greater Metropolitan Taskforce (Renal Services Network). Evidence Based Practice 
Guidelines for the Nutritional Management of Adult Kidney Transplant Recipients. 2008; 
http://www.daa.asn.au/files/DINER/TransplantNutrition_Guidelines_FINAL_090628.pdf. 
Accessed 8/16/10. 
69 
 
15. Teplan V, Valkovsky I, Teplan VJ, Stollova M, Vyhnanek F, Andel M. Nutritional 
consequences of renal transplantation. J Ren Nutr. 2009;19(1):95-100. 
 
16. Martins C, Pecoits-Filho R, Riella MC. Nutrition for the post-renal transplant recipients. 
Transplant Proc. Jul-Aug 2004;36(6):1650-1654. 
 
17. Pulgar EV, Ibarra-Ramírez F, Figueroa-Núñez B, Gómez Alonso C, Rodríguez-Orozco 
AR. Macronutrient consumption and lifestyle in patients whose received transplant of 
kidney in The Mexican Institute For Social Security. Nutr Hosp. 2010;25(1):107-112. 
 
18. Lopes I, Martin M, Errasti P, Martinez JA. Changes in the post-kidney transplantation 
body composition: different behavior between men and women. Nutr Hosp. Jan-Feb 
1998;13(1):28-32. 
 
19. Coroas A, Oliveira JG, Sampaio S, et al. Nutritional status and body composition 
evolution in early post-renal transplantation: is there a female advantage? Transplant 
Proc. Jul-Aug 2005;37(6):2765-2770. 
 
20. Nielens H, Lejeune TM, Lalaoui A, Squifflet JP, Pirson Y, Goffin E. Increase of physical 
activity level after successful renal transplantation: a 5 year follow-up study. Nephrol 
Dial Transplant. Jan 2001;16(1):134-140. 
 
21. van den Ham EC, Kooman JP, Christiaans MH, Leunissen KM, van Hooff JP. 
Posttransplantation weight gain is predominantly due to an increase in body fat mass. 
Transplantation. Jul 2000;70(1):241-242. 
 
22. Painter PL, Hector L, Ray K, et al. A randomized trial of exercise training after renal 
transplantation. Transplantation. 2002;74(1):42-48. 
 
23. El-Agroudy AE, Wafa EW, Gheith OE, Shehab el-Dein AB, Ghoneim MA. Weight gain 
after renal transplantation is a risk factor for patient and graft outcome. Transplantation. 
May 2004;77(9):1381-1385. 
 
24. McPartland KJ, Pomposelli JJ. Update on immunosuppressive drugs used in solid-organ 
transplantation and their nutrition implications. Nutr Clin Pract. Oct 2007;22(5):467-473. 
 
25. Weil S. Nutrition in the Kidney Transplant Recipient. In: Danovitch GM, ed. Handbook 
of Kidney Transplantation. 5th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & 
Wilkins; 2009. 
 
26. Elster EA LD, Morrissette C, Pepek JM, Quiko A, Hale DA, Chamberlain C, Salaita C, 
Kirk AD, Mannon RB. Obesity following kidney transplantation and steroid avoidance 
immunosuppression. Clin Transplantation. 2008; 22(3):354-359. 
 
27. van den Ham EC Kooman JP, Christiaans MH, Nieman FH, van Hooff JP. Weight 
changes after renal transplantation: a comparison between patients on 5-mg maintenance 
steroid therapy and those on steroid-free immunosuppressive therapy. Transpl Int. 
2003;16(5):300-306. 
 
28. Diaz JM, Sainz Z, Oliver A, et al. Post-renal transplantation weight gain: its causes and 
its consequences. Transplant Proc. Nov 2005;37(9):3839-3841. 
70 
 
29. Luk WS-C. The HRQoL of renal transplant patients. J Clin Nurs. 2004;13(2):201-209. 
 
30. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal 
transplantation. Am J Transplant. Feb 2006;6(2):357-363. 
 
31. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term 
survival in renal transplant recipients with graft function. Kidney Int. 2000;57(1):307-
313. 
 
32. Stipanuk MH. Nutrients: history and definitions. In: Stipanuk MH, ed. Biochemical 
Physiological Aspects of Human Nutrition. 2nd ed. St. Louis: Saunders Elsevier; 2006:3-
12. 
 
33. Institute of Medicine of the National Academies. Dietary Reference Intakes Tables and 
Application. 2002; http://www.iom.edu/Activities/Nutrition/SummaryDRIs/DRI-
Tables.aspx. Accessed 3/26/10. 
 
34. Hill JO, Melanson EL. Overview of the determinants of overweight and obesity: current 
evidence and research issues. Med Sci Sports Exerc. Nov 1999;31(11 Suppl):S515-521. 
 
35. World Health Organization. BMI Classification. 2010; 
http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. Accessed 4/25/10. 
 
36. United States Department of Health and Human Services. Physical Activity Guidelines 
for Americans. 2008; http://www.health.gov/paguidelines/guidelines/default.aspx#toc. 
Accessed 3/14/10. 
 
37. Aisworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an 
update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32 (9 
suppl):S498-S504. 
 
38. Sloane R, Snyder DC, Demark-Wahnefried W, Lobach D, Kraus WE. Comparing the 7-
day physical activity recall with a triaxial accelerometer for measuring time in exercise. 
Med Sci Sports Exerc. Jun 2009;41(6):1334-1340. 
 
39. Smeltzer SC, Bare BG. Brunner & Suddarth's Textbook of Medical-Surgical Nursing. 
Philadelphia: Lippincott Williams & Wilkins; 2000. 
 
40. DiCecco SR, Francisco-Killer N, Moore D. Overview of Imunosuppression. In: Hasse 
JM, Blue LS, eds. Comprehensive Guide toTransplant Nutrition. Chicago: American 
Dietetic Association; 2002:1-30. 
 
41. Danovitch GM. Immunosuppressive medications and protocols for kidney 
transplantation. In: Danovitch GM, ed. Handbook of Kidney Transplantation. 
Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010:79-99. 
 
42. Marcen R. Immunosuppressive drugs in kidney transplantation: impact on patient 
survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. Nov 
2009;69(16):2227-2243. 
 
71 
 
43. Gelb S, Shapiro RJ, Hill A, Thornton WL. Cognitive outcome following kidney 
transplantation. Nephrol. Dial. Transplant. 2008;23(3):1032-1038. 
 
44. Griva K, Thompson D, Jayasena D, Davenport A, Harrison M, Newman SP. Cognitive 
functioning pre- to post-kidney transplantation-a prospective study. Nephrol Dial 
Transplant. Nov 2006;21(11):3275-3282. 
 
45. Nutrition Coordinating Center University of Minnesota. 2010; 
http://www.ncc.umn.edu/services/recallcollection.html. Accessed 12/11/10. 
 
46. Willett W, ed. Nutritional Epidemiology 2nd ed. New York: Oxford University Press; 
1998. 
 
47. Aisworth BE, Haskell, W.L., Leon, A.S., et al. Compendium of physical activities: 
energy costs of human movement. Med. Sci Sports Exerc. 1993;25:71-80. 
 
48. Baum CL, Thielke K, Westin E, Kogan E, Cicalese L, Benedetti E. Predictors of weight 
gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. 
Nutrition. Feb 2002;18(2):139-146. 
 
49. El Haggan W, Vendrely B, Chauveau P, et al. Early evolution of nutritional status and 
body composition after kidney transplantation. Am J Kidney Dis. Sep 2002;40(3):629-
637. 
 
50. Gaziano JM. Fifth phase of the epidemiologic transition: The age of obesity and 
inactivity. JAMA. Jan 2010;303(3):275-276. 
 
51. World Health Organization. Obesity and overweight. 2006; 
http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 3/26/10. 
 
52. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on 
U.S. life expectancy. N Engl J Med. Dec 2009;361(23):2252-2260. 
 
53. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH. Validity 
of body mass index compared with other body-composition screening indexes for the 
assessment of body fatness in children and adolescents. Am J Clin Nutr. 2002; 
Jun;75(6):978-985. 
 
54. Center for Disease Control and Prevention. Defining Overweight and Obesity. 2010; 
http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html. Accessed 
3/14/10. 
 
55. Elmer PJ, Brown JB, Nichols GA, Oster G. Effects of weight gain on medical care costs. 
Int J Obes Relat Metab Disord. 2004;28(11):1365-1373. 
 
56. Guida B, Trio R, Laccetti R, et al. Role of dietary intervention on metabolic 
abnormalities and nutritional status after renal transplantation. Nephrol, Dial, Transplant. 
2007;22(11):3304-3310. 
 
57. Pischon T, Sharma AM. Obesity as a risk factor in renal transplant patients. Nephrol. 
Dial. Transplant. Jan 2001;16(1):14-17. 
72 
 
58. Merion RM, Twork AM, Rosenberg L, et al. Obesity and renal transplantation. Surg 
Gynecol Obstet. May 1991;172(5):367-376. 
 
59. Gill JS, Pereira BJG. Death in the first year after kidney transplantation: implications for 
patients on the transplant waiting list. Transplantation. 2003;75(1):113-117. 
 
60. Lopes IM, Martín M, Errasti P, Martínez JA. Benefits of a dietary intervention on weight 
loss, body composition, and lipid profile after renal transplantation. Nutrition. 
1999;15(1):7-10. 
 
61. Bellinghieri G, Bernardi A, Piva M, et al. Metabolic syndrome after kidney 
transplantation. J Ren Nutr. 2009;19(1):105-110. 
 
62. Jindal RM, Zawada ET, Jr. Obesity and kidney transplantation. Am J Kidney Dis. Jun 
2004;43(6):943-952. 
 
63. Aker S, Ivens K, Guo Z, Grabensee B, Heering P. Cardiovascular complications after 
renal transplantation. Transplant Proc. Aug 1998;30(5):2039-2042. 
 
64. Aker S, Ivens K, Grabensee B, Heering P. Cardiovascular risk factors and diseases after 
renal transplantation. Int Urol Nephrol. 1998;30(6):777-788. 
 
65. McLaughlin DP. Human Physiology. New York : Taylor & Francis; 2007. 
 
66. Lutz C, Przytulski K. Nutrition and Diet Therapy: Evidence-Based Applications. 4th ed. 
Philadelphia: FA Davis; 2006. 
 
67. McGilvery R. Biochemistry: A Functional Approach. Philadephia:W B Saunders; 1983. 
 
68. Van Pilsum JF. Metabolism of individual tissues. In: Devlin TS, ed. Textbook of 
Biochemistry with Clinical Correlation. New York: John Wiley & Sons, Inc.; 1982:1036-
1039. 
 
69. Stipanuk MH, Watford M. Amino acid metabolism. In: Stipanuk MH, ed. Biochemical, 
Physiological, Molecular Aspects of Human Nutrition. 2nd ed. St.Louis: Saunders 
Elsevier; 2006:360-418. 
 
70. Sheng H. Body fluids and water balance. In: Stipanuk MH, ed. Biochemical, 
physiological, molecular aspects of human nutrition. 2nd ed. St.Louis: Saunders Elsevier 
2006:973-1000. 
 
71. Friedman AN, Miskulin DC, Rosenberg IH, Levey AS. Demographics and trends in 
overweight and obesity in patients at time of kidney transplantation. Am J Kid Dis. 
2003;41(2):480-487. 
 
72. National Kidney Foundation. National Kidney Foundation’s Kidney Disease Outcome 
Quality Initiatives. 2000; 
http://www.kidney.org/professionals/kdoqi/guidelines/nut_a17.html. Accessed 4/ 25/10. 
 
73 
 
73. National Kidney Foundation. National Kidney Foundation’s Kidney Disease Outcome 
Quality Initiatives (2000). Management of Protein and Energy Intake 2000; 
http://www.kidney.org/professionals/kdoqi/guidelines/nut_a15.html. Accessed 4/ 25/10. 
 
74. de Luis D, Bustamante J. Nutritional aspects in renal failure. Nefrologia. 2008;28(3):333-
342. 
 
75. Kopple JD. Kidney transplantation. In: Kopple JD, Massey SG, eds. Nutritional 
Management of Renal Disease. Baltimore: Williams & Wilkins; 1997:691. 
 
76. Blue LS. Adult kidney transplantation. In: Hasse JM, Blue LS, eds. Comprehensive guide 
to transplant nutrition. Chicago: American Dietetic Association; 2002. 
 
77. Wilkinson A, Kasiske L. Long-Term post-tranplantation management and complications. 
In: Danovitch GM, ed. Handbook of Kidney Transplantation. Philadelphia: Wolters 
Kluwer/Lippincott Williams & Wilkins; 2009:217-260. 
 
78. Haggan WE, Vendrely B, Chauveau P, et al. Evolution of nutritional status and body 
composition after kidney transplantation. Am J Kid Dis. 2002;40(3):629-637. 
 
79. Stark C. Guidelines for food and nutrient intake In: Stipanuk MH, ed. Biochemical, 
Physiological, Molecular Aspects of Human Nutrition. 2nd ed. St. Louis: Saunders 
Elsevier; 2006:46-63. 
 
80. Murphy SP, Barr SI, Poos MI. Using the new dietary reference intakes to assess diets: a 
map to the maze. Nutr Rev. 2002;60(9):267-275. 
 
81. Buzzard M. 24-Hour dietary recall and food record methods. In: Willett W, ed. 
Nutritional Epidemiology. Vol 30. 2nd ed: Oxford University Press; 1998. 
 
82. Dwyer J, Picciano MF, Raiten DJ. Collection of food and dietary supplement intake data: 
What We Eat in America-NHANES. J Nutr. Feb 2003;133(2):590S-600S. 
 
83. Thompson FE, Subar AF. Dietary assessment methodology. In: Coulson AM, Boushey C, 
eds. Nutrition in the Prevention and Treatment of Disease. San Diego: Elsevier Academic 
Press; 2008:6. 
 
84. Beaton GH. Approaches to analysis of dietary data: relationship between planned 
analyses and choice of methodology. Am J Clin Nutr. Jan 1994;59(1 Suppl):253S-261S. 
 
85. Jackson KA, Byrne NM, Magarey AM, Hills AP. Minimizing random error in dietary 
intakes assessed by 24-h recall, in overweight and obese adults. Eur J Clin Nutr. 
2007;62(4):537-543. 
 
86. Sawaya AL, Tucker K, Tsay R, et al. Evaluation of four methods for determining energy 
intake in young and older women: comparison with doubly labeled water measurements 
of total energy expenditure. Am J Clin Nutr. Apr 1996;63(4):491-499. 
 
87. Buzzard IM, Faucett CL, Jeffery RW, et al. Monitoring dietary change in a low-fat diet 
intervention study: advantages of using 24-hour dietary recalls vs food records. J Am Diet 
Assoc. Jun 1996;96(6):574-579. 
74 
 
 
88. Schatzkin A, Kipnis V, Carroll RJ, et al. A comparison of a food frequency questionnaire 
with a 24-hour recall for use in an epidemiological cohort study: results from the 
biomarker-based Observing Protein and Energy Nutrition (OPEN) study. Int J Epidemiol. 
Dec 2003;32(6):1054-1062. 
 
89. Sievert YA, Schakel SF, Buzzard IM. Maintenance of a nutrient database for clinical 
trials. Control Clin Trials. Dec 1989;10(4):416-425. 
 
90. Nutrition Coordinating Center University of Minnesota. Mission and History. 2010; 
http://www.ncc.umn.edu/about/missionandhistory.html. Accessed 4/24/10. 
 
91. Nutrition Coordinating Center University of Minnesota. Foods, Nutrients and Food 
Groups. 2010; http://www.ncc.umn.edu/products/databasefoodsnutrientsfoodgroups.html. 
Accessed 4/24/10. 
 
92. Schakel SF, Buzzard IM, Gebhardt SE. Procedures for estimating nutrient values for food 
composition databases. J Food Comp Anal. 1997;10(2):102-114. 
 
93. Nutrition Coordinating Center University of Minnesota. Food and Nutrient Database. 
2010; http://www.ncc.umn.edu/products/database.html. Accessed 4/24/10. 
 
94. Buzzard IM, Feskanich D. Maintaining a food composition data base for multiple 
research studies: the NCC food table. Paper presented at: United Nations University's 
Food Data Systems Project (INFOODS). Mar 1985; Logan, Utah. 
 
95. Nutrition Coordinating Center University of Minnesota. NDSR Dietary Interviewer 
Training Manual. Minneapolis: University of Minnesota; 2007. 
 
96. Griffin P. Exercise and sport after organ transplantation. Br J Sports Med. Sep 
1998;32(3):194. 
 
97. Sanchez ZV, Cashion AK, Cowan PA, Jacob SR, Wicks MN, Velasquez-Mieyer P. 
Perceived barriers and facilitators to physical activity in kidney transplant recipients. 
Prog Transplant. Dec 2007;17(4):324-331. 
 
98. Kjaer M, Beyer N, Secher NH. Exercise and organ transplantation. Scand J Med Sci 
Sports. Feb 1999;9(1):1-14. 
 
99. Zakliczynski M, Spiechowicz U, Krynicka A, et al. Fluctuations of exercise capacity in 
patients after kidney transplantation. Transplant Proc. Jan-Feb 2009;41(1):184-187. 
 
100. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the 
Five-City Project. Am J Epidemiol. Jan 1985;121(1):91-106. 
 
101. Washburn RA JD, Sonko BJ, Hill JO, Donnelly JE. The validity of the Stanford Seven-
Day Physical Activity Recall in young adults. Med Sci Sports Exerc. 2003;35(8):1374-
1378. 
 
75 
 
102. DiCecco SR, Francisco-Killer N, Moore D. Overview and imunosuppression. In: Hasse 
JM, Blue LS, eds. Comprehensive Guide to Transplant Nutrition. Chicago: American 
Dietetic Association; 2002:1-30. 
 
103. Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Early steroid 
withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-
based calcineurin inhibitor-minimization protocol. Clin Transplant. Jan-Feb 
2007;21(1):101-109. 
 
104. Huether SE. Mechanisms of hormonal regulation. In: Huether SE, McCance KL, eds. 
Pathophysiology: The Biologic Basis for Disease in Adults & Children. Vol 1. 2nd ed. St. 
Louis: Mosby; 2002:463-464. 
 
105. Lin S, Cosgrove CJ. Perioperative management of immunosuppression. Surg Clin North 
Am. Oct 2006;86(5):1167-1183. 
 
106. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty 
acids. Am J Cardiol. Aug 21 2006;98(4A):27i-33i. 
 
107. Weil S. Nutrition in the kidney transplant recipient. In: Danovitch GM, ed. Handbook of 
Kidney Transplantation. 5th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & 
Wilkins; 2009. 
 
108. Ersoy A, Baran B, Ersoy C, Kahvecioglu S, Akdag I. Calcineurin inhibitors and post-
transplant weight gain. Nephrology. 2008;13(5):433-439. 
 
109. Blackburn G, Bistrian B, Maini B, Schlamm H, Smith M. Nutritional and metabolic 
assessment of the hospitalized patient. JPEN. 1977;1:11-22. 
 
110. Chang SH, McDonald SP. Post-kidney transplant weight change as marker of poor 
survival outcomes. Transplantation. May 2008;85(10):1443-1448. 
 
111. Magee T, Lee SM, Giuliano KK, Munro B. Generating new knowledge from existing 
data: the use of large data sets for nursing research. Nurs Res. Mar-Apr 2006;55(2 
Suppl):S50-56. 
 
112. Polit DF, Beck CT. Nursing Research: Generating and Assessing Evidence for Nursing 
Practice. 8th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. 
 
113. Block G. A review of validations of dietary assessment methods. Am J Epidemiol. Apr 
1982;115(4):492-505. 
 
114. Schakel SF. Maintaining a Nutrient Database in a Changing Marketplace: Keeping Pace 
with Changing Food Products—A Research Perspective J Food Comp Anal. 
2001;14(3):315-322. 
 
115. McCullough ML, Karanja NM, Lin PH, et al. Comparison of 4 nutrient databases with 
chemical composition data from the Dietary Approaches to Stop Hypertension trial. 
DASH Collaborative Research Group. J Am Diet Assoc. Aug 1999;99(8 Suppl):S45-53. 
 
76 
 
116. Nutrition Coordinating Center University of Minnesota. NDSR Features. 2009; 
http://www.ncc.umn.edu/products/ndsrfeatures.html. Accessed 3/1/10. 
 
117. Sallis JF, Buono M, Roby JJ, Micale FG, Nelson JA. Seven-day recall and other physical 
activity self-reports in children and adolescents. Med Sci Sports Exerc. 1993;25(1):99-
108. 
 
118. Gross LD, Sallis JF, Buono MJ, Nelson JA. Reliability of interviewers using the Seven-
Day Physical Activity Recall. Res Exerc Sport. 1990; 61(4):321-325. 
 
119. Taylor CB, Coffey T, Berra K, Iaffaldano R, Casey K, Haskell WL. Seven-Day activity 
and self-report compared to a direct measure of physical activity. Am. J. Epidemiol. Dec 
1984;120(6):818-824. 
 
120. Hayden-Wade HA, Coleman KJ, Sallis JE, Armstrong C. Validation of the telephone and 
in-person interview versions of the 7-Day PAR Med Sci Sports Exerc 2003;801-809 
 
121. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go 
from here? Science. Feb 2003;299(5608):853-855. 
 
122. Wolf AM, Colditz GA. Social and economic effects of body weight in the United States. 
Am J Clin Nutr. 1996;63:466s-469s. 
 
123. van den Ham EC, Kooman JP, van Hooff JP. Nutritional considerations in renal 
transplant patients. Blood Purif. 2002;20(2):139-144. 
 
124. Briggs JD. Causes of death after renal transplantation. Nephr Dial Transplant. Aug 2001; 
16(8):1545-1549. 
 
125. Heaf J, Jakobsen U, Tvedegaard E, Kanstrup I-L, Fogh-Andersen N. Dietary habits and 
nutritional status of renal transplant patients. J Ren Nutr. 2004;14(1):20-25. 
 
126. Lynch I, Eustace JA, Plant WD, Cashman KD, O'Keefe M, Lordan S, Moloney R. 
Inadequate dietary calcium and vitamin D intakes in renal-transplant recipients in Ireland. 
J Ren Nutr. 2007;17(6):408-415. 
 
127. Ewers B, Gasbjerg A, Moelgaard C, Frederiksen A, Marckmann P. Vitamin D status in 
kidney transplant patients: need for intensified routine supplementation. Am J Clinl Nutr. 
2008;87:431-437. 
 
128. Kamycheva E, Joakimsen R, Jorde R. Intakes of calcium and vitamin D predict body 
mass index in the population of northern Norway. J of Nutr. 2002:102-106. 
 
129. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among 
US adults, 1999-2008. JAMA. Jan 2010;303(3):235-241. 
 
 
77 
 
VITA 
 
 
Connie Klopfenstein Cupples was born in 1952 in Covington, Tennessee. She 
received a diploma in Nursing from Methodist Hospital School of Nursing and a 
Bachelor of Science in Nursing from Memphis State University. She received a Master of 
Science in Instruction and Curriculum Leadership with a focus in adult education from 
the University of Memphis. She received a Master of Science in Nursing with a focus on 
Nursing Education from Union University. Her thesis research explored reduction in 
cancer treatments side effects following an intervention. She was accepted to The 
University of Tennessee Health Science Center to pursue a PhD in Nursing in 2007. Her 
research in the PhD program focused on environmental factors associated with weight 
gain in kidney transplant recipients. She has presented at national and international 
nursing conferences. She has been a nurse educator for over 30 years and is currently an 
Assistant Professor of Nursing at Union University.    
 
